Global epidemiology of campylobacter infection

Clinical Microbiology Reviews

Volumn 28, Issue 3, 2015, Pages 687-720

  Kaakoush, Nadeem O ^a   Castaño Rodríguez, Natalia ^a   Mitchell, Hazel M ^a   Man, Si Ming ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; LEVOFLOXACIN; PROBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL TRANSMISSION; CAMPYLOBACTER CONCISUS; CAMPYLOBACTER JEJUNI; CAMPYLOBACTERIOSIS; CARDIOVASCULAR DISEASE; CELIAC DISEASE; CHOLECYSTITIS; COLORECTAL CANCER; DIARRHEA; ESOPHAGUS DISEASE; GASTROENTERITIS; GUILLAIN BARRE SYNDROME; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; LABORATORY DIAGNOSIS; MENINGITIS; META ANALYSIS (TOPIC); PERIODONTAL DISEASE; POLYMERASE CHAIN REACTION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REACTIVE ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; VACCINATION; ANIMAL; CAMPYLOBACTER INFECTIONS; COMMUNICABLE DISEASES, EMERGING; DISEASE CARRIER; FOOD CONTROL; PATHOLOGY; TRANSMISSION;

ANIMALIA; CAMPYLOBACTER;

ANIMALS; CAMPYLOBACTER INFECTIONS; COMMUNICABLE DISEASES, EMERGING; DISEASE RESERVOIRS; FOOD MICROBIOLOGY; HUMANS; INCIDENCE; PREVALENCE; RISK FACTORS;

EID: 84933503429     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00006-15     Document Type: Article

References (447)

1. Man SM. 2011. The clinical importance of emerging Campylobacter species. Nat Rev Gastroenterol Hepatol 8:669–685. http://dx.doi.org/10.1038/nrgastro.2011.191.
2. Vandamme P, Dewhirst FE, Paster BJ, On SLW. 2005. Campylobacteraceae, p 1147–1160. In Garrity GM, Brenner DJ, Krieg NR, Staley JT (ed), Bergey’s manual of systematic bacteriology, vol 2. Springer Science, New York, NY.
3. Sebald M, Veron M. 1963. Base DNA content and classification of vibrios. Ann Inst Pasteur (Paris) 105:897–910.
4. Black RE, Levine MM, Clements ML, Hughes TP, Blaser MJ. 1988. Experimental Campylobacter jejuni infection in humans. J Infect Dis 157: 472–479. http://dx.doi.org/10.1093/infdis/157.3.472.
5. Hara-Kudo Y, Takatori K. 2011. Contamination level and ingestion dose of foodborne pathogens associated with infections. Epidemiol Infect 139:1505–1510. http://dx.doi.org/10.1017/S095026881000292X.
6. Medema GJ, Teunis PF, Havelaar AH, Haas CN. 1996. Assessment of the dose-response relationship of Campylobacter jejuni. Int J Food Microbiol 30:101–111. http://dx.doi.org/10.1016/0168-1605(96)00994-4.
7. Tribble DR, Baqar S, Scott DA, Oplinger ML, Trespalacios F, Rollins D, Walker RI, Clements JD, Walz S, Gibbs P, Burg EF, III, Moran AP, Applebee L, Bourgeois AL. 2010. Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans. Infect Immun 78:1750–1759. http://dx.doi.org/10.1128/IAI.01021-09.
8. Kirkpatrick BD, Lyon CE, Porter CK, Maue AC, Guerry P, Pierce KK, Carmolli MP, Riddle MS, Larsson CJ, Hawk D, Dill EA, Fingar A, Poly F, Fimlaid K, Hoq F, Tribble DR. 2013. Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge model. Clin Infect Dis 57:1106–1113. http://dx.doi.org/10.1093/cid/cit454.
9. Baqar S, Tribble DR, Carmolli M, Sadigh K, Poly F, Porter C, Larsson CJ, Pierce KK, Guerry P, Darsley M, Kirkpatrick B. 2010. Recrudescent Campylobacter jejuni infection in an immunocompetent adult following experimental infection with a well-characterized organism. Clin Vaccine Immunol 17:80–86. http://dx.doi.org/10.1128/CVI.00252-09.
10. Blaser MJ. 1997. Epidemiologic and clinical features of Campylobacter jejuni infections. J Infect Dis 176(Suppl 2):S103–S105. http://dx.doi.org/10.1086/513780.
11. Nielsen HL, Ejlertsen T, Engberg J, Nielsen H. 2013. High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: a population-based study. Clin Microbiol Infect 19:445–450. http://dx.doi.org/10.1111/j.1469-0691.2012.03852.x.
12. Bessede E, Lehours P, Labadi L, Bakiri S, Megraud F. 2014. Comparison of characteristics of patients infected by Campylobacter jejuni, Campylobacter coli, and Campylobacter fetus. J Clin Microbiol 52:328–330. http://dx.doi.org/10.1128/JCM.03029-13.
13. Rao MR, Naficy AB, Savarino SJ, Abu-Elyazeed R, Wierzba TF, Peruski LF, Abdel-Messih I, Frenck R, Clemens JD. 2001. Pathogenicity and convalescent excretion of Campylobacter in rural Egyptian children. Am J Epidemiol 154:166–173. http://dx.doi.org/10.1093/aje/154.2.166.
14. Inglis GD, Boras VF, Houde A. 2011. Enteric campylobacteria and RNA viruses associated with healthy and diarrheic humans in the Chinook Heath Region of Southwestern Alberta, Canada. J Clin Microbiol 49: 209–219. http://dx.doi.org/10.1128/JCM.01220-10.
15. Karmali MA, Penner JL, Fleming PC, Williams A, Hennessy JN. 1983. The serotype and biotype distribution of clinical isolates of Campylobacter jejuni and Campylobacter coli over a three-year period. J Infect Dis 147:243–246. http://dx.doi.org/10.1093/infdis/147.2.243.
16. Gurtler M, Alter T, Kasimir S, Fehlhaber K. 2005. The importance of Campylobacter coli in human campylobacteriosis: prevalence and genetic characterization. Epidemiol Infect 133:1081–1087. http://dx.doi.org/10.1017/S0950268805004164.
17. Hamidian M, Sanaei M, Bolfion M, Dabiri H, Zali MR, Walther- Rasmussen J. 2011. Prevalence of putative virulence markers in Campylobacter jejuni and Campylobacter coli isolated from hospitalized children, raw chicken, and raw beef in Tehran, Iran. Can J Microbiol 57:143–148. http://dx.doi.org/10.1139/W10-089.
18. Friedman CR, Hoekstra RM, Samuel M, Marcus R, Bender J, Shiferaw B, Reddy S, Ahuja SD, Helfrick DL, Hardnett F, Carter M, Anderson B, Tauxe RV. 2004. Risk factors for sporadic Campylobacter infection in the United States: a case-control study in FoodNet sites. Clin Infect Dis 38(Suppl 3):S285–S296. http://dx.doi.org/10.1086/381598.
19. Adak GK, Meakins SM, Yip H, Lopman BA, O’Brien SJ. 2005. Disease risks from foods, England and Wales, 1996–2000. Emerg Infect Dis 11: 365–372. http://dx.doi.org/10.3201/eid1103.040191.
20. Hall G, Kirk MD, Becker N, Gregory JE, Unicomb L, Millard G, Stafford R, Lalor K. 2005. Estimating foodborne gastroenteritis, Australia. Emerg Infect Dis 11:1257–1264. http://dx.doi.org/10.3201/eid1108.041367.
21. Tam CC, O’Brien SJ, Tompkins DS, Bolton FJ, Berry L, Dodds J, Choudhury D, Halstead F, Iturriza-Gomara M, Mather K, Rait G, Ridge A, Rodrigues LC, Wain J, Wood B, Gray JJ. 2012. Changes in causes of acute gastroenteritis in the United Kingdom over 15 years: microbiologic findings from 2 prospective, population-based studies of infectious intestinal disease. Clin Infect Dis 54:1275–1286. http://dx.doi.org/10.1093/cid/cis028.
22. Casanova C, Schweiger A, von Steiger N, Droz S, Marschall J. 2015. Campylobacter concisus pseudo-outbreak caused by improved culture conditions. J Clin Microbiol 53:660–662. http://dx.doi.org/10.1128/JCM.02608-14.
23. Nielsen HL, Engberg J, Ejlertsen T, Bucker R, Nielsen H. 2012. Short-term and medium-term clinical outcomes of Campylobacter concisus infection. Clin Microbiol Infect 18:E459–E465. http://dx.doi.org/10.1111/j.1469-0691.2012.03990.x.
24. Nielsen HL, Engberg J, Ejlertsen T, Nielsen H. 2013. Evaluation of fecal calprotectin in Campylobacter concisus and Campylobacter jejuni/coli gastroenteritis. Scand J Gastroenterol 48:633–635. http://dx.doi.org/10.3109/00365521.2013.775329.
25. Sadkowska-Todys M, Kucharczyk B. 2012. Campylobacteriosis in Poland in 2010. Przegl Epidemiol 66:255–258.
26. Kubota K, Kasuga F, Iwasaki E, Inagaki S, Sakurai Y, Komatsu M, Toyofuku H, Angulo FJ, Scallan E, Morikawa K. 2011. Estimating the burden of acute gastroenteritis and foodborne illness caused by Campylobacter, Salmonella, and Vibrio parahaemolyticus by using populationbased telephone survey data, Miyagi Prefecture, Japan, 2005 to 2006. J Food Prot 74:1592–1598. http://dx.doi.org/10.4315/0362-028X.JFP-10-387.
27. Wagenaar JA, French NP, Havelaar AH. 2013. Preventing Campylobacter at the source: why is it so difficult? Clin Infect Dis 57:1600–1606. http://dx.doi.org/10.1093/cid/cit555.
28. Havelaar AH, van Pelt W, Ang CW, Wagenaar JA, van Putten JP, Gross U, Newell DG. 2009. Immunity to Campylobacter: its role in risk assessment and epidemiology. Crit Rev Microbiol 35:1–22. http://dx.doi.org/10.1080/10408410802636017.
29. Tompkins DS, Hudson MJ, Smith HR, Eglin RP, Wheeler JG, Brett MM, Owen RJ, Brazier JS, Cumberland P, King V, Cook PE. 1999. A study of infectious intestinal disease in England: microbiological findings in cases and controls. Commun Dis Public Health 2:108–113.
30. de Wit MA, Koopmans MP, Kortbeek LM, Wannet WJ, Vinje J, van Leusden F, Bartelds AI, van Duynhoven YT. 2001. Sensor, a population- based cohort study on gastroenteritis in the Netherlands: incidence and etiology. Am J Epidemiol 154:666–674. http://dx.doi.org/10.1093/aje/154.7.666.
31. Little CL, Gormley FJ, Rawal N, Richardson JF. 2010. A recipe for disaster: outbreaks of campylobacteriosis associated with poultry liver pate in England and Wales. Epidemiol Infect 138:1691–1694. http://dx.doi.org/10.1017/S0950268810001974.
32. Batz MB, Hoffmann S, Morris JG, Jr. 2012. Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation. J Food Prot 75:1278–1291. http://dx.doi.org/10.4315/0362-028X.JFP-11-418.
33. Hall AJ, Wikswo ME, Manikonda K, Roberts VA, Yoder JS, Gould LH. 2013. Acute gastroenteritis surveillance through the National Outbreak Reporting System, United States. Emerg Infect Dis 19:1305–1309. http://dx.doi.org/10.3201/eid1908.130482.
34. Gilliss D, Cronquist AB, Cartter M, Tobin-D’Angelo M, Blythe D, Smith K, Lathrop S, Zansky S, Cieslak PR, Dunn J, Holt KG, Lance S, Crim SM, Henao OL, Patrick M, Griffin PM, Tauxe RV. 2013. Incidence and trends of infection with pathogens transmitted commonly through food—foodborne diseases active surveillance network, 10 U.S. sites, 1996–2012. MMWR Morb Mortal Wkly Rep 62:283–287.
35. Hoffmann S, Batz MB, Morris JG, Jr. 2012. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J Food Prot 75:1292–1302. http://dx.doi.org/10.4315/0362-028X.JFP-11-417.
36. Kendall ME, Crim S, Fullerton K, Han PV, Cronquist AB, Shiferaw B, Ingram LA, Rounds J, Mintz ED, Mahon BE. 2012. Travel-associated enteric infections diagnosed after return to the United States, Foodborne Diseases Active Surveillance Network (FoodNet), 2004–2009. Clin Infect Dis 54(Suppl 5):S480–S487. http://dx.doi.org/10.1093/cid/cis052.
37. Arsenault J, Berke O, Michel P, Ravel A, Gosselin P. 2012. Environmental and demographic risk factors for campylobacteriosis: do various geographical scales tell the same story? BMC Infect Dis 12:318. http://dx.doi.org/10.1186/1471-2334-12-318.
38. Keegan VA, Majowicz SE, Pearl DL, Marshall BJ, Sittler N, Knowles L, Wilson JB. 2009. Epidemiology of enteric disease in C-EnterNet’s pilot site—Waterloo region, Ontario, 1990 to 2004. Can J Infect Dis Med Microbiol 20:79–87.
39. BC Centre for Disease Control. 2011, posting date. British Columbia annual summary of reportable diseases. BC Centre for Disease Control, Vancouver, British Columbia, Canada.
40. Larrosa-Haro A, Macias-Rosales R, Sanchez-Ramirez CA, Cortes- Lopez MC, Aguilar-Benavides S. 2010. Seasonal variation of enteropathogens in infants and preschoolers with acute diarrhea in western Mexico. J Pediatr Gastroenterol Nutr 51:534–536. http://dx.doi.org/10.1097/MPG.0b013e3181df5b66.
41. Benoit SR, Lopez B, Arvelo W, Henao O, Parsons MB, Reyes L, Moir JC, Lindblade K. 2014. Burden of laboratory-confirmed Campylobacter infections in Guatemala 2008–2012: results from a facility-based surveillance system. J Epidemiol Glob Health 4:51–59. http://dx.doi.org/10.1016/j.jegh.2013.10.001.
42. Workman SN, Sobers SJ, Mathison GE, Lavoie MC. 2006. Human Campylobacter-associated enteritis on the Caribbean island of Barbados. Am J Trop Med Hyg 74:623–627.
43. Fernández H. 2011. Campylobacter and campylobacteriosis: a view from South America. Rev Peru Med Exp Salud Publica 28:121–127. http://dx.doi.org/10.1590/S1726-46342011000100019.
44. Collado L, Gutierrez M, Gonzalez M, Fernandez H. 2013. Assessment of the prevalence and diversity of emergent campylobacteria in human stool samples using a combination of traditional and molecular methods. Diagn Microbiol Infect Dis 75:434–436. http://dx.doi.org/10.1016/j.diagmicrobio.2012.12.006.
45. Platts-Mills JA, Liu J, Gratz J, Mduma E, Amour C, Swai N, Taniuchi M, Begum S, Penataro Yori P, Tilley DH, Lee G, Shen Z, Whary MT, Fox JG, McGrath M, Kosek M, Haque R, Houpt ER. 2014. Detection of Campylobacter in stool and determination of significance by culture, enzyme immunoassay, and PCR in developing countries. J Clin Microbiol 52:1074–1080. http://dx.doi.org/10.1128/JCM.02935-13.
46. Havelaar AH, Ivarsson S, Lofdahl M, Nauta MJ. 2013. Estimating the true incidence of campylobacteriosis and salmonellosis in the European Union, 2009. Epidemiol Infect 141:293–302. http://dx.doi.org/10.1017/S0950268812000568.
47. Tam CC, Rodrigues LC, Viviani L, Dodds JP, Evans MR, Hunter PR, Gray JJ, Letley LH, Rait G, Tompkins DS, O’Brien SJ. 2012. Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut 61:69–77. http://dx.doi.org/10.1136/gut.2011.238386.
48. Stingl K, Knüver MT, Vogt P, Buhler C, Krüger NJ, Alt K, Tenhagen BA, Hartung M, Schroeter A, Ellerbroek L, Appel B, Käsbohrer A. 2012. Quo vadis? Monitoring Campylobacter in Germany. Eur J Microbiol Immunol 2:88–96. http://dx.doi.org/10.1556/EuJMI.2.2012.1.12.
49. Hauri AM, Just M, McFarland S, Schweigmann A, Schlez K, Krahn J. 2013. Campylobacteriosis outbreaks in the state of Hesse, Germany, 2005–2011: raw milk yet again. Dtsch Med Wochenschr 138:357–361. http://dx.doi.org/10.1055/s-0032-1332884.
50. Sadkowska-Todys M, Kucharczyk B. 2014. Campylobacteriosis in Poland in 2012. Przegl Epidemiol 68:239–241, 249–251.
51. Bouwknegt M, van Pelt W, Havelaar AH. 2013. Scoping the impact of changes in population age-structure on the future burden of foodborne disease in the Netherlands, 2020–2060. Int J Environ Res Public Health 10:2888–2896. http://dx.doi.org/10.3390/ijerph10072888.
52. Havelaar AH, Nauta MJ, Mangen MJJ, de Koeijer AG, Bogaardt M-J, Evers EG, Jacobs-Reitsma WF, van Pelt W, Wagenaar JA, de Wit GA, van der Zee H. 29 July 2005, posting date. Costs and benefits of controlling Campylobacter in the Netherlands—integrating risk analysis, epidemiology and economics. National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
53. Sivadon-Tardy V, Porcher R, Orlikowski D, Ronco E, Gault E, Roussi J, Durand MC, Sharshar T, Annane D, Raphael JC, Megraud F, Gaillard JL. 2014. Increased incidence of Campylobacter jejuniassociated Guillain-Barre syndromes in the Greater Paris area. Epidemiol Infect 142:1609–1613. http://dx.doi.org/10.1017/S095026881300263X.
54. de Boer RF, Ott A, Guren P, van Zanten E, van Belkum A, Kooistra- Smid AM. 2013. Detection of Campylobacter species and Arcobacter butzleri in stool samples by use of real-time multiplex PCR. J Clin Microbiol 51:253–259. http://dx.doi.org/10.1128/JCM.01716-12.
55. Nielsen HL, Engberg J, Ejlertsen T, Nielsen H. 2013. Clinical manifestations of Campylobacter concisus infection in children. Pediatr Infect Dis J 32:1194–1198. http://dx.doi.org/10.1097/INF.0b013e31829f0aff.
56. Ferreira S, Julio C, Queiroz JA, Domingues FC, Oleastro M. 2014. Molecular diagnosis of Arcobacter and Campylobacter in diarrhoeal samples among Portuguese patients. Diagn Microbiol Infect Dis 78:220–225. http://dx.doi.org/10.1016/j.diagmicrobio.2013.11.021.
57. Koziel M, Kiely R, Blake L, O’Callaghan I, Corcoran GD, Lucey B, Sleator RD. 2013. Improved detection of bacterial pathogens in patients presenting with gastroenteritis by use of the EntericBio real-time Gastro Panel I assay. J Clin Microbiol 51:2679–2685. http://dx.doi.org/10.1128/JCM.00809-13.
58. Bullman S, Corcoran D, O’Leary J, Lucey B, Byrne D, Sleator RD. 2011. Campylobacter ureolyticus: an emerging gastrointestinal pathogen? FEMS Immunol Med Microbiol 61:228–230. http://dx.doi.org/10.1111/j.1574-695X.2010.00760.x.
59. Bullman S, Corcoran D, O’Leary J, O’Hare D, Lucey B, Sleator RD. 2011. Emerging dynamics of human campylobacteriosis in southern Ireland. FEMS Immunol Med Microbiol 63:248–253. http://dx.doi.org/10.1111/j.1574-695X.2011.00847.x.
60. Huang JL, Xu HY, Bao GY, Zhou XH, Ji DJ, Zhang G, Liu PH, Jiang F, Pan ZM, Liu XF, Jiao XA. 2009. Epidemiological surveillance of Campylobacter jejuni in chicken, dairy cattle and diarrhoea patients. Epidemiol Infect 137:1111–1120. http://dx.doi.org/10.1017/S0950268809002039.
61. Chen J, Sun XT, Zeng Z, Yu YY. 2011. Campylobacter enteritis in adult patients with acute diarrhea from 2005 to 2009 in Beijing, China. Chin Med J (Engl) 124:1508–1512.
62. Wang J, Guo YC, Li N. 2013. Prevalence and risk assessment of Campylobacter jejuni in chicken in China. Biomed Environ Sci 26:243–248. http://dx.doi.org/10.3967/0895-3988.2013.04.002.
63. Mukherjee P, Ramamurthy T, Bhattacharya MK, Rajendran K, Mukhopadhyay AK. 2013. Campylobacter jejuni in hospitalized patients with diarrhea, Kolkata, India. Emerg Infect Dis 19:1155–1156. http://dx.doi.org/10.3201/eid1907.121278.
64. Sinha A, SenGupta S, Guin S, Dutta S, Ghosh S, Mukherjee P, Mukhopadhyay AK, Ramamurthy T, Takeda Y, Kurakawa T, Nomoto K, Nair GB, Nandy RK. 2013. Culture-independent real-time PCR reveals extensive polymicrobial infections in hospitalized diarrhoea cases in Kolkata, India. Clin Microbiol Infect 19:173–180. http://dx.doi.org/10.1111/j.1469-0691.2011.03746.x.
65. Rajendran P, Babji S, George AT, Rajan DP, Kang G, Ajjampur SS. 2012. Detection and species identification of Campylobacter in stool samples of children and animals from Vellore, South India. Indian J Med Microbiol 30:85–88. http://dx.doi.org/10.4103/0255-0857.93049.
66. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, Faruque AS, Zaidi AK, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ochieng JB, Omore R, Oundo JO, Hossain A, Das SK, Ahmed S, Qureshi S, Quadri F, Adegbola RA, Antonio M, Hossain MJ, Akinsola A, Mandomando I, Nhampossa T, Acacio S, Biswas K, O’Reilly CE, Mintz ED, Berkeley LY, Muhsen K, Sommerfelt H, Robins-Browne RM, Levine MM. 2013. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382:209–222. http://dx.doi.org/10.1016/S0140-6736(13)60844-2.
67. Weinberger M, Lerner L, Valinsky L, Moran-Gilad J, Nissan I, Agmon V, Peretz C. 2013. Increased incidence of Campylobacter spp. infection and high rates among children, Israel. Emerg Infect Dis 19:1828–1831. http://dx.doi.org/10.3201/eid1911.120900.
68. Dayan N, Revivo D, Even L, Elkayam O, Glikman D. 2010. Campylobacter is the leading cause of bacterial gastroenteritis and dysentery in hospitalized children in the Western Galilee Region in Israel. Epidemiol Infect 138:1405–1406. http://dx.doi.org/10.1017/S0950268810000737.
69. OzFoodNet Working Group. 2012. Monitoring the incidence and causes of diseases potentially transmitted by food in Australia: annual report of the OzFoodNet network, 2010. Commun Dis Intell Q Rep 36:E213–E241.
70. OzFoodNet Working Group. 2010. Monitoring the incidence and causes of diseases potentially transmitted by food in Australia: annual report of the OzFoodNet network, 2009. Commun Dis Intell Q Rep 34:396–426.
71. OzFoodNet Working Group. 2009. Monitoring the incidence and causes of diseases potentially transmitted by food in Australia: annual report of the OzFoodNet network, 2008. Commun Dis Intell Q Rep 33:389–413.
72. Gibney KB, O’Toole J, Sinclair M, Leder K. 2014. Disease burden of selected gastrointestinal pathogens in Australia, 2010. Int J Infect Dis 28:176–185. http://dx.doi.org/10.1016/j.ijid.2014.08.006.
73. Sears A, Baker MG, Wilson N, Marshall J, Muellner P, Campbell DM, Lake RJ, French NP. 2011. Marked campylobacteriosis decline after interventions aimed at poultry, New Zealand. Emerg Infect Dis 17:1007–1015. http://dx.doi.org/10.3201/eid/1706.101272.
74. Gilpin BJ, Walsh G, On SL, Smith D, Marshall JC, French NP. 2013. Application of molecular epidemiology to understanding campylobacteriosis in the Canterbury region of New Zealand. Epidemiol Infect 141: 1253–1266. http://dx.doi.org/10.1017/S0950268812001719.
75. Cornelius AJ, Chambers S, Aitken J, Brandt SM, Horn B, On SL. 2012. Epsilonproteobacteria in humans, New Zealand. Emerg Infect Dis 18: 510–512. http://dx.doi.org/10.3201/eid1803.110875.
76. Howard P, Alexander ND, Atkinson A, Clegg AO, Gerega G, Javati A, Kajoi M, Lupiwa S, Lupiwa T, Mens M, Saleu G, Sanders RC, West B, Alpers MP. 2000. Bacterial, viral and parasitic aetiology of paediatric diarrhoea in the highlands of Papua New Guinea. J Trop Pediatr 46:10–14. http://dx.doi.org/10.1093/tropej/46.1.10.
77. Mason J, Iturriza-Gomara M, O’Brien SJ, Ngwira BM, Dove W, Maiden MC, Cunliffe NA. 2013. Campylobacter infection in children in Malawi is common and is frequently associated with enteric virus coinfections. PLoS One 8:e59663. http://dx.doi.org/10.1371/journal.pone.0059663.
78. Randremanana RV, Randrianirina F, Sabatier P, Rakotonirina HC, Randriamanantena A, Razanajatovo IM, Ratovoson R, Richard V. 2014. Campylobacter infection in a cohort of rural children in Moramanga, Madagascar. BMC Infect Dis 14:372. http://dx.doi.org/10.1186/1471-2334-14-372.
79. Swierczewski BE, Odundo EA, Koech MC, Ndonye JN, Kirera RK, Odhiambo CP, Cheruiyot EK, Shaffer DN, Ombogo AN, Oaks EV. 2013. Enteric pathogen surveillance in a case-control study of acute diarrhea in Kisii Town, Kenya. J Med Microbiol 62:1774–1776. http://dx.doi.org/10.1099/jmm.0.059139-0.
80. Lastovica A. 2006. Emerging Campylobacter spp.: the tip of the iceberg. Clin Microbiol Newsl 28:49–56. http://dx.doi.org/10.1016/j.clinmicnews.2006.03.004.
81. Lastovica AJ. 2009. Clinical relevance of Campylobacter concisus isolated from pediatric patients. J Clin Microbiol 47:2360. http://dx.doi.org/10.1128/JCM.00568-09.
82. Man SM, Kaakoush NO, Mitchell HM. 2011. The role of bacteria and pattern-recognition receptors in Crohn’s disease. Nat Rev Gastroenterol Hepatol 8:152–168. http://dx.doi.org/10.1038/nrgastro.2011.3.
83. Blaser MJ, Hoverson D, Ely IG, Duncan DJ, Wang WL, Brown WR. 1984. Studies of Campylobacter jejuni in patients with inflammatory bowel disease. Gastroenterology 86:33–38.
84. Weber P, Koch M, Heizmann WR, Scheurlen M, Jenss H, Hartmann F. 1992. Microbic superinfection in relapse of inflammatory bowel disease. J Clin Gastroenterol 14:302–308. http://dx.doi.org/10.1097/00004836-199206000-00008.
85. Boyanova L, Gergova G, Spassova Z, Koumanova R, Yaneva P, Mitov I, Derejian S, Krastev Z. 2004. Campylobacter infection in 682 Bulgarian patients with acute enterocolitis, inflammatory bowel disease, and other chronic intestinal diseases. Diagn Microbiol Infect Dis 49:71–74. http://dx.doi.org/10.1016/j.diagmicrobio.2003.12.004.
86. Gradel KO, Nielsen HL, Schonheyder HC, Ejlertsen T, Kristensen B, Nielsen H. 2009. Increased short- and long-term risk of inflammatory bowel disease after Salmonella or Campylobacter gastroenteritis. Gastroenterology 137:495–501. http://dx.doi.org/10.1053/j.gastro.2009.04.001.
87. Zhang L, Man SM, Day AS, Leach ST, Lemberg DA, Dutt S, Stormon M, Otley A, O’Loughlin EV, Magoffin A, Ng PH, Mitchell H. 2009. Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn’s disease. J Clin Microbiol 47:453–455. http://dx.doi.org/10.1128/JCM.01949-08.
88. Tankovic J, Burghoffer B, Petit JC. 2009. Frequent detection by realtime PCR of bacteria from the Helicobacter and Campylobacter genera in stool samples from inflammatory bowel disease patients, abstr R2084. Abstr 19th Eur Congr Clin Microbiol Infect Dis, Helsinki, Finland.
89. Man SM, Zhang L, Day AS, Leach ST, Lemberg DA, Mitchell H. 2010. Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn’s disease. Inflamm Bowel Dis 16:1008–1016. http://dx.doi.org/10.1002/ibd.21157.
90. Kaakoush NO, Day AS, Huinao KD, Leach ST, Lemberg DA, Dowd SE, Mitchell HM. 2012. Microbial dysbiosis in pediatric patients with Crohn’s disease. J Clin Microbiol 50:3258–3266. http://dx.doi.org/10.1128/JCM.01396-12.
91. Mahendran V, Riordan SM, Grimm MC, Tran TAT, Major J, Kaakoush NO, Mitchell H, Zhang L. 2011. Prevalence of Campylobacter species in adult Crohn’s disease and the preferential colonization sites of Campylobacter species in the human intestine. PLoS One 6:e25417. http://dx.doi.org/10.1371/journal.pone.0025417.
92. Hansen R, Berry SH, Mukhopadhya I, Thomson JM, Saunders KA, Nicholl CE, Bisset WM, Loganathan S, Mahdi G, Kastner-Cole D, Barclay AR, Bishop J, Flynn DM, McGrogan P, Russell RK, El-Omar EM, Hold GL. 2013. The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: The BISCUIT Study. PLoS One 8:e58825. http://dx.doi.org/10.1371/journal.pone.0058825.
93. Mukhopadhya I, Thomson JM, Hansen R, Berry SH, El-Omar EM, Hold GL. 2011. Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis. PLoS One 6:e21490. http://dx.doi.org/10.1371/journal.pone.0021490.
94. Rajilic-Stojanovic M, Shanahan F, Guarner F, de Vos WM. 2013. Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflamm Bowel Dis 19:481–488. http://dx.doi.org/10.1097/MIB.0b013e31827fec6d.
95. Zhang L, Budiman V, Day AS, Mitchell H, Lemberg DA, Riordan SM, Grimm M, Leach ST, Ismail Y. 2010. Isolation and detection of Campylobacter concisus from saliva of healthy individuals and patients with inflammatory bowel disease. J Clin Microbiol 48:2965–2967. http://dx.doi.org/10.1128/JCM.02391-09.
96. O’Brien CL, Pavli P, Gordon DM, Allison GE. 2014. Detection of bacterial DNA in lymph nodes of Crohn’s disease patients using high throughput sequencing. Gut 63:1596–1606. http://dx.doi.org/10.1136/gutjnl-2013-305320.
97. Kovach Z, Kaakoush NO, Lamb S, Zhang L, Raftery MJ, Mitchell H. 2011. Immunoreactive proteins of Campylobacter concisus, an emergent intestinal pathogen. FEMS Immunol Med Microbiol 63:387–396. http://dx.doi.org/10.1111/j.1574-695X.2011.00864.x.
98. Kaakoush NO, Mitchell HM, Man SM. 2014. Role of emerging Campylobacter species in inflammatory bowel diseases. Inflamm Bowel Dis 20:2189–2197. http://dx.doi.org/10.1097/MIB.0000000000000074.
99. Matsheka MI, Elisha BG, Lastovica AL, On SL. 2002. Genetic heterogeneity of Campylobacter concisus determined by pulsed field gel electrophoresis- based macrorestriction profiling. FEMS Microbiol Lett 211:17–22. http://dx.doi.org/10.1111/j.1574-6968.2002.tb11197.x.
100. Matsheka MI, Lastovica AJ, Zappe H, Elisha BG. 2006. The use of (GTG)5 oligonucleotide as an RAPD primer to type Campylobacter concisus. Lett Appl Microbiol 42:600–605. http://dx.doi.org/10.1111/j.1472-765X.2006.01900.x.
101. Aabenhus R, Permin H, On SL, Andersen LP. 2002. Prevalence of Campylobacter concisus in diarrhoea of immunocompromised patients. Scand J Infect Dis 34:248–252. http://dx.doi.org/10.1080/00365540110080566.
102. Aabenhus R, On SL, Siemer BL, Permin H, Andersen LP. 2005. Delineation of Campylobacter concisus genomospecies by amplified fragment length polymorphism analysis and correlation of results with clinical data. J Clin Microbiol 43:5091–5096. http://dx.doi.org/10.1128/JCM.43.10.5091-5096.2005.
103. Aabenhus R, Permin H, Andersen LP. 2005. Characterization and subgrouping of Campylobacter concisus strains using protein profiles, conventional biochemical testing and antibiotic susceptibility. Eur J Gastroenterol Hepatol 17:1019–1024. http://dx.doi.org/10.1097/00042737-200510000-00003.
104. Engberg J, Bang DD, Aabenhus R, Aarestrup FM, Fussing V, Gerner- Smidt P. 2005. Campylobacter concisus: an evaluation of certain phenotypic and genotypic characteristics. Clin Microbiol Infect 11:288–295. http://dx.doi.org/10.1111/j.1469-0691.2005.01111.x.
105. On SL, Harrington CS. 2000. Identification of taxonomic and epidemiological relationships among Campylobacter species by numerical analysis of AFLP profiles. FEMS Microbiol Lett 193:161–169. http://dx.doi.org/10.1111/j.1574-6968.2000.tb09419.x.
106. Kaakoush NO, Castano-Rodriguez N, Day AS, Lemberg DA, Leach ST, Mitchell HM. 2014. Campylobacter concisus and exotoxin 9 levels in paediatric patients with Crohn’s disease and their association with the intestinal microbiota. J Med Microbiol 63:99–105. http://dx.doi.org/10.1099/jmm.0.067231-0.
107. Deshpande NP, Kaakoush NO, Wilkins MR, Mitchell HM. 2013. Comparative genomics of Campylobacter concisus isolates reveals genetic diversity and provides insights into disease association. BMC Genomics 14:585. http://dx.doi.org/10.1186/1471-2164-14-585.
108. Kaakoush NO, Deshpande NP, Wilkins MR, Tan CG, Burgos- Portugal JA, Raftery MJ, Day AS, Lemberg DA, Mitchell H. 2011. The pathogenic potential of Campylobacter concisus strains associated with chronic intestinal diseases. PLoS One 6:e29045. http://dx.doi.org/10.1371/journal.pone.0029045.
109. Kaakoush NO, Man SM, Lamb S, Raftery MJ, Wilkins MR, Kovach Z, Mitchell H. 2010. The secretome of Campylobacter concisus. FEBS J 277: 1606–1617. http://dx.doi.org/10.1111/j.1742-4658.2010.07587.x.
110. Kaakoush NO, Castaño-Rodríguez N, Day AS, Lemberg DA, Leach ST, Mitchell HM. 2015. Faecal levels of zonula occludens toxin in paediatric patients with Crohn’s disease and their association with the intestinal microbiota. J Med Microbiol 64:303–306. http://dx.doi.org/10.1099/jmm.0.000005.
111. Man SM, Kaakoush NO, Leach ST, Nahidi L, Lu HK, Norman J, Day AS, Zhang L, Mitchell HM. 2010. Host attachment, invasion, and stimulation of proinflammatory cytokines by Campylobacter concisus and other non-Campylobacter jejuni Campylobacter species. J Infect Dis 202: 1855–1865. http://dx.doi.org/10.1086/657316.
112. Kaakoush NO, Deshpande NP, Man SM, Burgos-Portugal JA, Khattak FA, Raftery MJ, Wilkins MR, Mitchell HM. 2015. Transcriptomic and proteomic analyses reveal key innate immune signatures in the host response to the gastrointestinal pathogen Campylobacter concisus. Infect Immun 83:832–845. http://dx.doi.org/10.1128/IAI.03012-14.
113. Macfarlane S, Furrie E, Macfarlane GT, Dillon JF. 2007. Microbial colonization of the upper gastrointestinal tract in patients with Barrett’s esophagus. Clin Infect Dis 45:29–38. http://dx.doi.org/10.1086/518578.
114. Pei Z, Bini EJ, Yang L, Zhou M, Francois F, Blaser MJ. 2004. Bacterial biota in the human distal esophagus. Proc Natl Acad SciUSA101:4250–4255. http://dx.doi.org/10.1073/pnas.0306398101.
115. Pei Z, Yang L, Peek RM, Jr, Levine SM, Pride DT, Blaser MJ. 2005. Bacterial biota in reflux esophagitis and Barrett’s esophagus. World J Gastroenterol 11:7277–7283. http://dx.doi.org/10.3748/wjg.v11.i46.7277.
116. Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z. 2009. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 137:588–597. http://dx.doi.org/10.1053/j.gastro.2009.04.046.
117. Liu N, Ando T, Ishiguro K, Maeda O, Watanabe O, Funasaka K, Nakamura M, Miyahara R, Ohmiya N, Goto H. 2013. Characterization of bacterial biota in the distal esophagus of Japanese patients with reflux esophagitis and Barrett’s esophagus. BMC Infect Dis 13:130. http://dx.doi.org/10.1186/1471-2334-13-130.
118. Osias GL, Bromer MQ, Thomas RM, Friedel D, Miller LS, Suh B, Lorber B, Parkman HP, Fisher RS. 2004. Esophageal bacteria and Barrett’s esophagus: a preliminary report. Dig Dis Sci 49:228–236. http://dx.doi.org/10.1023/B:DDAS.0000017443.44802.4b.
119. Blackett KL, Siddhi SS, Cleary S, Steed H, Miller MH, Macfarlane S, Macfarlane GT, Dillon JF. 2013. Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett’s and oesophageal carcinoma: association or causality? Aliment Pharmacol Ther 37:1084–1092. http://dx.doi.org/10.1111/apt.12317.
120. Palma G, Barbieri A, Bimonte S, Palla M, Zappavigna S, Caraglia M, Ascierto PA, Ciliberto G, Arra C. 2013. Interleukin 18: friend or foe in cancer. Biochim Biophys Acta 1836:296–303. http://dx.doi.org/10.1016/j.bbcan.2013.09.001.
121. Macuch PJ, Tanner AC. 2000. Campylobacter species in health, gingivitis, and periodontitis. J Dent Res 79:785–792. http://dx.doi.org/10.1177/00220345000790021301.
122. Kaakoush NO, Mitchell HM. 2012. Campylobacter concisus—a new player in intestinal disease. Front Cell Infect Microbiol 2:4. http://dx.doi.org/10.3389/fcimb.2012.00004.
123. Etoh Y, Dewhirst FE, Paster BJ, Yamamoto A, Goto N. 1993. Campylobacter showae sp. nov., isolated from the human oral cavity. Int J Syst Bacteriol 43:631–639. http://dx.doi.org/10.1099/00207713-43-4-631.
124. Loesche WJ, Gibbons RJ, Socransky SS. 1965. Biochemical characteristics of Vibrio sputorum and relationship to Vibrio bubulus and Vibrio fetus. J Bacteriol 89:1109–1116.
125. van Palenstein Helderman WH. 1975. Total viable count and differential count of Vibrio (Campylobacter) sputorum, Fusobacterium nucleatum, Selenomonas sputigena, Bacteroides ochraceus and Veillonella in the inflamed and noninflamed human gingival crevice. J Periodont Res 10: 294–305. http://dx.doi.org/10.1111/j.1600-0765.1975.tb00037.x.
126. Duerden BI, Goodwin L, O’Neil TC. 1987. Identification of Bacteroides species from adult periodontal disease. J Med Microbiol 24:133–137. http://dx.doi.org/10.1099/00222615-24-2-133.
127. Tanner AC, Dzink JL, Ebersole JL, Socransky SS. 1987. Wolinella recta, Campylobacter concisus, Bacteroides gracilis, and Eikenella corrodens from periodontal lesions. J Periodont Res 22:327–330. http://dx.doi.org/10.1111/j.1600-0765.1987.tb01593.x.
128. Tanner ACR, Badger S, Lai CH, Listarten MA, Visconti RA, Socransky SS. 1981. Wolinella gen. nov., Wolinella succinogenes (Vibrio succinogenes Wolin et al.) comb. nov., and description of Bacteroides gracilis sp. nov., Wolinella recta sp. nov., Campylobacter concisus sp. nov., and Eikenella corrodens from humans with periodontal disease. Int J Syst Bacteriol 31:432–445. http://dx.doi.org/10.1099/00207713-31-4-432.
129. Henne K, Fuchs F, Kruth S, Horz HP, Conrads G. 2014. Shifts in Campylobacter species abundance may reflect general microbial community shifts in periodontitis progression. J Oral Microbiol 6:25874. http://dx.doi.org/10.3402/jom.v6.25874.
130. Lee HJ, Kim JK, Cho JY, Lee JM, Hong SH. 2012. Quantification of subgingival bacterial pathogens at different stages of periodontal diseases. Curr Microbiol 65:22–27. http://dx.doi.org/10.1007/s00284-012-0121-8.
131. Lopez R, Dahlen G, Retamales C, Baelum V. 2011. Clustering of subgingival microbial species in adolescents with periodontitis. Eur J Oral Sci 119: 141–150. http://dx.doi.org/10.1111/j.1600-0722.2011.00808.x.
132. von Troil-Linden B, Torkko H, Alaluusua S, Jousimies-Somer H, Asikainen S. 1995. Salivary levels of suspected periodontal pathogens in relation to periodontal status and treatment. J Dent Res 74:1789–1795. http://dx.doi.org/10.1177/00220345950740111201.
133. Ihara H, Miura T, Kato T, Ishihara K, Nakagawa T, Yamada S, Okuda K. 2003. Detection of Campylobacter rectus in periodontitis sites by monoclonal antibodies. J Periodont Res 38:64–72. http://dx.doi.org/10.1034/j.1600-0765.2003.01627.x.
134. Tanner A, Maiden MF, Macuch PJ, Murray LL, Kent RL, Jr. 1998. Microbiota of health, gingivitis, and initial periodontitis. J Clin Periodontol 25:85–98. http://dx.doi.org/10.1111/j.1600-051X.1998.tb02414.x.
135. Aas JA, Griffen AL, Dardis SR, Lee AM, Olsen I, Dewhirst FE, Leys EJ, Paster BJ. 2008. Bacteria of dental caries in primary and permanent teeth in children and young adults. J Clin Microbiol 46:1407–1417. http://dx.doi.org/10.1128/JCM.01410-07.
136. Johnson CC, Reinhardt JF, Edelstein MA, Mulligan ME, George WL, Finegold SM. 1985. Bacteroides gracilis, an important anaerobic bacterial pathogen. J Clin Microbiol 22:799–802.
137. Rawlinson A, Eleys K, Bennett KW, Goodwin L. 1994. Bacteroides gracilis in periodontal health and disease. Microb Ecol Health Dis 7:201–205. http://dx.doi.org/10.3109/08910609409141355.
138. Shen S, Samaranayake LP, Yip HK. 2005. Coaggregation profiles of the microflora from root surface caries lesions. Arch Oral Biol 50:23–32. http://dx.doi.org/10.1016/j.archoralbio.2004.07.002.
139. Haririan H, Andrukhov O, Bertl K, Lettner S, Kierstein S, Moritz A, Rausch-Fan X. 2014. Microbial analysis of subgingival plaque samples compared to that of whole saliva in patients with periodontitis. J Periodontol 85:819–828. http://dx.doi.org/10.1902/jop.2013.130306.
140. Moore WE, Holdeman LV, Cato EP, Smibert RM, Burmeister JA, Palcanis KG, Ranney RR. 1985. Comparative bacteriology of juvenile periodontitis. Infect Immun 48:507–519.
141. Moore LV, Moore WE, Cato EP, Smibert RM, Burmeister JA, Best AM, Ranney RR. 1987. Bacteriology of human gingivitis. J Dent Res 66:989–995. http://dx.doi.org/10.1177/00220345870660052401.
142. Kamma JJ, Nakou M, Manti FA. 1994. Microbiota of rapidly progressive periodontitis lesions in association with clinical parameters. J Periodontol 65:1073–1078. http://dx.doi.org/10.1902/jop.1994.65.11.1073.
143. Ebersole JL, Taubman MA, Smith DJ, Haffajee AD. 1985. Effect of subgingival scaling on systemic antibody responses to oral microorganisms. Infect Immun 48:534–539.
144. Taubman MA, Haffajee AD, Socransky SS, Smith DJ, Ebersole JL. 1992. Longitudinal monitoring of humoral antibody in subjects with destructive periodontal diseases. J Periodont Res 27:511–521. http://dx.doi.org/10.1111/j.1600-0765.1992.tb01825.x.
145. Haffajee AD, Socransky SS, Ebersole JL, Smith DJ. 1984. Clinical, microbiological and immunological features associated with the treatment of active periodontosis lesions. J Clin Periodontol 11:600–618. http://dx.doi.org/10.1111/j.1600-051X.1984.tb00913.x.
146. Ercan E, Eratalay K, Deren O, Gur D, Ozyuncu O, Altun B, Kanli C, Ozdemir P, Akincibay H. 2013. Evaluation of periodontal pathogens in amniotic fluid and the role of periodontal disease in pre-term birth and low birth weight. Acta Odontol Scand 71:553–559. http://dx.doi.org/10.3109/00016357.2012.697576.
147. Brito F, Zaltman C, Carvalho AT, Fischer RG, Persson R, Gustafsson A, Figueredo CM. 2013. Subgingival microflora in inflammatory bowel disease patients with untreated periodontitis. Eur J Gastroenterol Hepatol 25:239–245. http://dx.doi.org/10.1097/MEG.0b013e32835a2b70.
148. Ismail Y, Mahendran V, Octavia S, Day AS, Riordan SM, Grimm MC, Lan R, Lemberg D, Tran TA, Zhang L. 2012. Investigation of the enteric pathogenic potential of oral Campylobacter concisus strains isolated from patients with inflammatory bowel disease. PLoS One 7:e38217. http://dx.doi.org/10.1371/journal.pone.0038217.
149. Van Dyke TE, Dowell VR, Jr, Offenbacher S, Snyder W, Hersh T. 1986. Potential role of microorganisms isolated from periodontal lesions in the pathogenesis of inflammatory bowel disease. Infect Immun 53: 671–677.
150. Moss-Morris R, Spence M. 2006. To “lump” or to “split” the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome? Psychosom Med 68:463–469. http://dx.doi.org/10.1097/01.psy.0000221384.07521.05.
151. Neal KR, Hebden J, Spiller R. 1997. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 314:779–782. http://dx.doi.org/10.1136/bmj.314.7083.779.
152. Dunlop SP, Jenkins D, Neal KR, Spiller RC. 2003. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 125:1651–1659. http://dx.doi.org/10.1053/j.gastro.2003.09.028.
153. Stermer E, Lubezky A, Potasman I, Paster E, Lavy A. 2006. Is traveler’s diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. Clin Infect Dis 43:898–901. http://dx.doi.org/10.1086/507540.
154. Marshall JK, Thabane M, Garg AX, Clark WF, Salvadori M, Collins SM. 2006. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 131:445–450. http://dx.doi.org/10.1053/j.gastro.2006.05.053.
155. Okhuysen PC, Jiang ZD, Carlin L, Forbes C, DuPont HL. 2004. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol 99:1774–1778. http://dx.doi.org/10.1111/j.1572-0241.2004.30435.x.
156. Saps M, Pensabene L, Di Martino L, Staiano A, Wechsler J, Zheng X, Di Lorenzo C. 2008. Post-infectious functional gastrointestinal disorders in children. J Pediatr 152:812–816, 816.e1. http://dx.doi.org/10.1016/j.jpeds.2007.11.042.
157. Futagami S, Itoh T, Sakamoto C. 2015. Systematic review with metaanalysis: post-infectious functional dyspepsia. Aliment Pharmacol Ther 41:177–188. http://dx.doi.org/10.1111/apt.13006.
158. Ford AC, Thabane M, Collins SM, Moayyedi P, Garg AX, Clark WF, Marshall JK. 2010. Prevalence of uninvestigated dyspepsia 8 years after a large waterborne outbreak of bacterial dysentery: a cohort study. Gastroenterology 138:1727–1736. http://dx.doi.org/10.1053/j.gastro.2010.01.043.
159. Porter CK, Choi D, Cash B, Pimentel M, Murray J, May L, Riddle MS. 2013. Pathogen-specific risk of chronic gastrointestinal disorders following bacterial causes of foodborne illness. BMC Gastroenterol 13:46. http://dx.doi.org/10.1186/1471-230X-13-46.
160. Parry SD, Stansfield R, Jelley D, Gregory W, Phillips E, Barton JR, Welfare MR. 2003. Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study. Am J Gastroenterol 98:1970–1975. http://dx.doi.org/10.1111/j.1572-0241.2003.07664.x.
161. Futagami S, Shindo T, Kawagoe T, Horie A, Shimpuku M, Gudis K, Iwakiri K, Itoh T, Sakamoto C. 2010. Migration of eosinophils and CCR2-/CD68-double positive cells into the duodenal mucosa of patients with postinfectious functional dyspepsia. Am J Gastroenterol 105:1835–1842. http://dx.doi.org/10.1038/ajg.2010.151.
162. Drossman DA. 2006. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 130:1377–1390. http://dx.doi.org/10.1053/j.gastro.2006.03.008.
163. Spiller R, Garsed K. 2009. Postinfectious irritable bowel syndrome. Gastroenterology 136:1979–1988. http://dx.doi.org/10.1053/j.gastro.2009.02.074.
164. Thornley JP, Jenkins D, Neal K, Wright T, Brough J, Spiller RC. 2001. Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome. J Infect Dis 184:606–609. http://dx.doi.org/10.1086/322845.
165. Marshall JK, Thabane M, Garg AX, Clark WF, Moayyedi P, Collins SM. 2010. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut 59:605–611. http://dx.doi.org/10.1136/gut.2009.202234.
166. Schwille-Kiuntke J, Enck P, Zendler C, Krieg M, Polster AV, Klosterhalfen S, Autenrieth IB, Zipfel S, Frick JS. 2011. Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter. Neurogastroenterol Motil 23:e479–e488. http://dx.doi.org/10.1111/j.1365-2982.2011.01779.x.
167. Grover M, Camilleri M, Smith K, Linden DR, Farrugia G. 2014. On the fiftieth anniversary. Postinfectious irritable bowel syndrome: mechanisms related to pathogens. Neurogastroenterol Motil 26:156–167. http://dx.doi.org/10.1111/nmo.12304.
168. Nielsen HL, Engberg J, Ejlertsen T, Nielsen H. 2014. Psychometric scores and persistence of irritable bowel after Campylobacter concisus infection. Scand J Gastroenterol 49:545–551. http://dx.doi.org/10.3109/00365521.2014.886718.
169. Warren RL, Freeman DJ, Pleasance S, Watson P, Moore RA, Cochrane K, Allen-Vercoe E, Holt RA. 2013. Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome 1:16. http://dx.doi.org/10.1186/2049-2618-1-16.
170. Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, Baselga J, Liu C, Shivdasani RA, Ogino S, Birren BW, Huttenhower C, Garrett WS, Meyerson M. 2012. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 22:292–298. http://dx.doi.org/10.1101/gr.126573.111.
171. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA. 2012. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 22:299–306. http://dx.doi.org/10.1101/gr.126516.111.
172. Wu N, Yang X, Zhang R, Li J, Xiao X, Hu Y, Chen Y, Yang F, Lu N, Wang Z, Luan C, Liu Y, Wang B, Xiang C, Wang Y, Zhao F, Gao GF, Wang S, Li L, Zhang H, Zhu B. 2013. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb Ecol 66:462–470. http://dx.doi.org/10.1007/s00248-013-0245-9.
173. Riddle MS, Gutierrez RL, Verdu EF, Porter CK. 2012. The chronic gastrointestinal consequences associated with Campylobacter. Curr Gastroenterol Rep 14:395–405. http://dx.doi.org/10.1007/s11894-012-0278-0.
174. Altobelli E, Paduano R, Petrocelli R, Di Orio F. 2014. Burden of celiac disease in Europe: a review of its childhood and adulthood prevalence and incidence as of September 2014. Ann Ig 26:485–498. http://dx.doi.org/10.7416/ai.2014.2007.
175. Riddle MS, Murray JA, Porter CK. 2012. The incidence and risk of celiac disease in a healthy US adult population. Am J Gastroenterol 107: 1248–1255. http://dx.doi.org/10.1038/ajg.2012.130.
176. Verdu EF, Mauro M, Bourgeois J, Armstrong D. 2007. Clinical onset of celiac disease after an episode of Campylobacter jejuni enteritis. Can J Gastroenterol 21:453–455.
177. Riddle MS, Murray JA, Cash BD, Pimentel M, Porter CK. 2013. Pathogen-specific risk of celiac disease following bacterial causes of foodborne illness: a retrospective cohort study. Dig Dis Sci 58:3242–3245. http://dx.doi.org/10.1007/s10620-013-2733-7.
178. Vaughan-Shaw PG, Rees JR, White D, Burgess P. 2010. Campylobacter jejuni cholecystitis: a rare but significant clinical entity. BMJ Case Rep 2010: bcr 1020092365. http://dx.doi.org/10.1136/bcr.10.2009.2365.
179. Landry O. 1859. Note sur la paralysie ascendante aigue. Gaz Hebd Med Chir 6:472–474, 486–488.
180. van Doorn PA, Ruts L, Jacobs BC. 2008. Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome. Lancet Neurol 7:939–950. http://dx.doi.org/10.1016/S1474-4422(08)70215-1.
181. Guillain G, Barré J, Strohl A. 1916. Sur un syndrome de radiculonevrite avec hyperalbuminose du liquide cephalorachidien sans reaction cellulaire. Remarques sur les caracteres cliniques et graphiques des reflexes tendineux. Bull Soc Med Hop Paris 28:1462–1470.
182. Kuwabara S, Yuki N. 2013. Axonal Guillain-Barre syndrome: concepts and controversies. Lancet Neurol 12:1180–1188. http://dx.doi.org/10.1016/S1474-4422(13)70215-1.
183. Bae JS, Yuki N, Kuwabara S, Kim JK, Vucic S, Lin CS, Kiernan MC. 2014. Guillain-Barre syndrome in Asia. J Neurol Neurosurg Psychiatry 85:907–913. http://dx.doi.org/10.1136/jnnp-2013-306212.
184. Baker MG, Kvalsvig A, Zhang J, Lake R, Sears A, Wilson N. 2012. Declining Guillain-Barre syndrome after campylobacteriosis control, New Zealand, 1988–2010. Emerg Infect Dis 18:226–233. http://dx.doi.org/10.3201/eid1802.111126.
185. Jackson BR, Zegarra JA, Lopez-Gatell H, Sejvar J, Arzate F, Waterman S, Nunez AS, Lopez B, Weiss J, Cruz RQ, Murrieta DY, Luna-Gierke R, Heiman K, Vieira AR, Fitzgerald C, Kwan P, Zarate-Bermudez M, Talkington D, Hill VR, Mahon B. 2014. Binational outbreak of Guillain- Barre syndrome associated with Campylobacter jejuni infection, Mexico and USA, 2011. Epidemiol Infect 142:1089–1099. http://dx.doi.org/10.1017/S0950268813001908.
186. Keithlin J, Sargeant J, Thomas MK, Fazil A. 2014. Systematic review and meta-analysis of the proportion of Campylobacter cases that develop chronic sequelae.BMCPublic Health 14:1203. http://dx.doi.org/10.1186/1471-2458-14-1203.
187. Freddo L, Yu RK, Latov N, Donofrio PD, Hays AP, Greenberg HS, Albers JW, Allessi AG, Keren D. 1986. Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease. Neurology 36:454–458. http://dx.doi.org/10.1212/WNL.36.4.454.
188. Bax M, Kuijf ML, Heikema AP, van Rijs W, Bruijns SC, Garcia-Vallejo JJ, Crocker PR, Jacobs BC, van Vliet SJ, van Kooyk Y. 2011. Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner. Infect Immun 79:2681–2689. http://dx.doi.org/10.1128/IAI.00009-11.
189. Heikema AP, Koning RI, Duarte Dos Santos Rico S, Rempel H, Jacobs BC, Endtz HP, van Wamel WJ, Samsom JN. 2013. Enhanced, sialoadhesin- dependent uptake of Guillain-Barre syndrome-associated Campylobacter jejuni strains by human macrophages. Infect Immun 81:2095– 2103. http://dx.doi.org/10.1128/IAI.01437-12.
190. Malik A, Sharma D, St Charles J, Dybas LA, Mansfield LS. 2014. Contrasting immune responses mediate Campylobacter jejuni-induced colitis and autoimmunity. Mucosal Immunol 7:802–817. http://dx.doi.org/10.1038/mi.2013.97.
191. Taboada EN, van Belkum A, Yuki N, Acedillo RR, Godschalk PC, Koga M, Endtz HP, Gilbert M, Nash JH. 2007. Comparative genomic analysis of Campylobacter jejuni associated with Guillain-Barre and Miller Fisher syndromes: neuropathogenic and enteritis-associated isolates can share high levels of genomic similarity. BMC Genomics 8:359. http://dx.doi.org/10.1186/1471-2164-8-359.
192. Fisher M. 1956. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 255: 57–65. http://dx.doi.org/10.1056/NEJM195607122550201.
193. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. 1992. Serum IgG antibody to gangliosideGQ1bis a possible marker of Miller Fisher syndrome. Ann Neurol 31:677–679. http://dx.doi.org/10.1002/ana.410310619.
194. Koga M, Gilbert M, Li J, Koike S, Takahashi M, Furukawa K, Hirata K, Yuki N. 2005. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology 64:1605–1611. http://dx.doi.org/10.1212/01.WNL.0000160399.08456.7C.
195. Heikema AP, Jacobs BC, Horst-Kreft D, Huizinga R, Kuijf ML, Endtz HP, Samsom JN, van Wamel WJ. 2013. Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barre syndrome and Miller Fisher syndrome. Clin Microbiol Infect 19:E106–E112. http://dx.doi.org/10.1111/1469-0691.12073.
196. Lee KY. 2012. Anti-GQ1b-negative Miller Fisher syndrome after Campylobacter jejuni enteritis. Pediatr Neurol 47:213–215. http://dx.doi.org/10.1016/j.pediatrneurol.2012.04.024.
197. Koga M, Gilbert M, Takahashi M, Li J, Hirata K, Kanda T, Yuki N. 2012. GQ1b-seronegative Fisher syndrome: clinical features and new serological markers. J Neurol 259:1366–1374. http://dx.doi.org/10.1007/s00415-011-6360-y.
198. Oyazato Y, Shiihara T, Kusunoki S, Adachi M, Ohnishi N, Taniguchi H, Nishiyama A, Watanabe A, Kobayashi M, Kamioka I. 2012. A case of anti-GA1 antibody-positive Fisher syndrome with elevated tau protein in cerebrospinal fluid. Brain Dev 34:329–332. http://dx.doi.org/10.1016/j.braindev.2011.06.007.
199. Tauxe RV, Patton CM, Edmonds P, Barrett TJ, Brenner DJ, Blake PA. 1985. Illness associated with Campylobacter laridis, a newly recognized Campylobacter species. J Clin Microbiol 21:222–225.
200. Chua K, Gurtler V, Montgomery J, Fraenkel M, Mayall BC, Grayson ML. 2007. Campylobacter insulaenigrae causing septicaemia and enteritis. J Med Microbiol 56:1565–1567. http://dx.doi.org/10.1099/jmm.0.47366-0.
201. Louwen R, Baarlen P, Vliet AH, Belkum A, Hays JP, Endtz HP. 2012. Campylobacter bacteremia: a rare and under-reported event? Eur J Microbiol Immunol 2:76–87. http://dx.doi.org/10.1556/EuJMI.2.2012.1.11.
202. Pigrau C, Bartolome R, Almirante B, Planes AM, Gavalda J, Pahissa A. 1997. Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns. Clin Infect Dis 25:1414–1420. http://dx.doi.org/10.1086/516127.
203. Pacanowski J, Lalande V, Lacombe K, Boudraa C, Lesprit P, Legrand P, Trystram D, Kassis N, Arlet G, Mainardi JL, Doucet-Populaire F, Girard PM, Meynard JL. 2008. Campylobacter bacteremia: clinical features and factors associated with fatal outcome. Clin Infect Dis 47:790–796. http://dx.doi.org/10.1086/591530.
204. Liao CH, Chuang CY, Huang YT, Lee PI, Hsueh PR. 2012. Bacteremia caused by antimicrobial resistant Campylobacter species at a medical center in Taiwan, 1998–2008. J Infect 65:392–399. http://dx.doi.org/10.1016/j.jinf.2012.06.014.
205. Nielsen H, Hansen KK, Gradel KO, Kristensen B, Ejlertsen T, Ostergaard C, Schonheyder HC. 2010. Bacteraemia as a result of Campylobacter species: a population-based study of epidemiology and clinical risk factors. Clin Microbiol Infect 16:57–61. http://dx.doi.org/10.1111/j.1469-0691.2009.02900.x.
206. Feodoroff B, Lauhio A, Ellstrom P, Rautelin H. 2011. A nationwide study of Campylobacter jejuni and Campylobacter coli bacteremia in Finland over a 10-year period, 1998–2007, with special reference to clinical characteristics and antimicrobial susceptibility. Clin Infect Dis 53:e99–e106. http://dx.doi.org/10.1093/cid/cir509.
207. Ben-Shimol S, Carmi A, Greenberg D. 2013. Demographic and clinical characteristics of Campylobacter bacteremia in children with and without predisposing factors. Pediatr Infect Dis J 32:e414–e418. http://dx.doi.org/10.1097/INF.0b013e31829baae0.
208. Blaser MJ, Perez GP, Smith PF, Patton C, Tenover FC, Lastovica AJ, Wang WI. 1986. Extraintestinal Campylobacter jejuni and Campylobacter coli infections: host factors and strain characteristics. J Infect Dis 153: 552–559. http://dx.doi.org/10.1093/infdis/153.3.552.
209. Nagy MT, Hla SM. 2013. Campylobacter fetus sepsis in an immunocompetent patient with haematological complication. BMJ Case Rep 2013: bcr2013008610. http://dx.doi.org/10.1136/bcr-2013-008610.
210. Chusid MJ, Wortmann DW, Dunne WM. 1990. “Campylobacter upsaliensis” sepsis in a boy with acquired hypogammaglobulinemia. Diagn Microbiol Infect Dis 13:367–369. http://dx.doi.org/10.1016/0732-8893(90)90003-E.
211. Fujihara N, Takakura S, Saito T, Iinuma Y, Ichiyama S. 2006. A case of perinatal sepsis by Campylobacter fetus subsp. fetus infection successfully treated with carbapenem—case report and literature review. J Infect 53: e199–e202. http://dx.doi.org/10.1016/j.jinf.2006.01.009.
212. Becker S, Ejlertsen T, Kristensen B, Norgaard M, Nielsen H. 2007. Is the incidence of perimyocarditis increased following Campylobacter jejuni infection? Eur J Clin Microbiol Infect Dis 26:927–929. http://dx.doi.org/10.1007/s10096-007-0393-2.
213. Florkowski CM, Ikram RB, Crozier IM, Ikram H, Berry ME. 1984. Campylobacter jejuni myocarditis. Clin Cardiol 7:558–559. http://dx.doi.org/10.1002/clc.4960071008.
214. Cox ID, Fluck DS, Joy MD. 2001. Campylobacter myocarditis; loose bowels and a baggy heart. Eur J Heart Fail 3:105–107. http://dx.doi.org/10.1016/S1388-9842(00)00093-3.
215. Westling K, Evengard B. 2001. Myocarditis associated with Campylobacter infection. Scand J Infect Dis 33:877–878. http://dx.doi.org/10.1080/003655401753186286.
216. Cunningham C, Lee CH. 2003. Myocarditis related to Campylobacter jejuni infection: a case report. BMC Infect Dis 3:16. http://dx.doi.org/10.1186/1471-2334-3-16.
217. Reda E, Mansell C. 2005. Myocarditis in a patient with Campylobacter infection. N Z Med J 118:U1634.
218. Mera V, Lopez T, Serralta J. 2007. Take traveller’s diarrhoea to heart. Travel Med Infect Dis 5:202–203. http://dx.doi.org/10.1016/j.tmaid.2006.11.001.
219. Pena LA, Fishbein MC. 2007. Fatal myocarditis related to Campylobacter jejuni infection: a case report. Cardiovasc Pathol 16:119–121. http://dx.doi.org/10.1016/j.carpath.2006.09.007.
220. Braun KP, Theissig F, Ernst H, May M, Krulls-Munch J. 2008. Campylobacter jejuni-associated hepatitis and myocardial injury. Med Klin (Munich) 103:346–348. http://dx.doi.org/10.1007/s00063-008-1042-y.
221. Turley AJ, Crilley JG, Hall JA. 2008. Acute myocarditis secondary to Campylobacter jejuni enterocolitis. Resuscitation 79:165–167. http://dx.doi.org/10.1016/j.resuscitation.2008.04.021.
222. Kratzer C, Wolf F, Graninger W, Weissel M. 2010. Acute cardiac disease in a young patient with Campylobacter jejuni infection: a case report. Wien Klin Wochenschr 122:315–319. http://dx.doi.org/10.1007/s00508-010-1381-6.
223. Ponka A, Pitkanen T, Pettersson T, Aittoniemi S, Kosunen TU. 1980. Carditis and arthritis associated with Campylobacter jejuni infection. Acta Med Scand 208:495–496.
224. Hull SR, Varma MP. 2011. Myopericarditis following Campylobacter infection. Ir J Med Sci 180:753–755. http://dx.doi.org/10.1007/s11845-009-0314-8.
225. Alzand BS, Ilhan M, Heesen WF, Meeder JG. 2010. Campylobacter jejuni: enterocolitis and myopericarditis. Int J Cardiol 144:e14–e16. http://dx.doi.org/10.1016/j.ijcard.2008.12.101.
226. Panikkath R, Costilla V, Hoang P, Wood J, Gruden JF, Dietrich B, Gotway MB, Appleton C. 2014. Chest pain and diarrhea: a case of Campylobacter jejuni-associated myocarditis. J Emerg Med 46:180–183. http://dx.doi.org/10.1016/j.jemermed.2013.08.060.
227. Murphy D, Jolly C, MacDonald S, Troughton R. 2013. Myocarditis associated with Campylobacter jejuni. N Z Med J 126:95–98.
228. De Cock D, Hiltrop N, Timmermans P, Dymarkowski S, Van Cleemput J. 2012. Myocarditis associated with Campylobacter enteritis: report of three cases. Circ Heart Fail 5:e19–e21. http://dx.doi.org/10.1161/CIRCHEARTFAILURE.111.964882.
229. Kotilainen P, Lehtopolku M, Hakanen AJ. 2006. Myopericarditis in a patient with Campylobacter enteritis: a case report and literature review. Scand J Infect Dis 38:549–552. http://dx.doi.org/10.1080/00365540500372903.
230. Hannu T, Mattila L, Rautelin H, Siitonen A, Leirisalo-Repo M. 2005. Three cases of cardiac complications associated with Campylobacter jejuni infection and review of the literature. Eur J Clin Microbiol Infect Dis 24:619–622. http://dx.doi.org/10.1007/s10096-005-0001-2.
231. Abbass K, Emig M, Bernstein JM. 2011. Sepsis and pericarditis caused by Campylobacter fetus: case report and literature review. J Ark Med Soc 108:88–89.
232. Uzoigwe C. 2005. Campylobacter infections of the pericardium and myo- cardium. Clin Microbiol Infect 11:253–255. http://dx.doi.org/10.1111/j.1469-0691.2004.01028.x.
233. Farrugia DC, Eykyn SJ, Smyth EG. 1994. Campylobacter fetus endocarditis: two case reports and review. Clin Infect Dis 18:443–446. http://dx.doi.org/10.1093/clinids/18.3.443.
234. Dinant S, Schurink CA, Deckers JW, Severin JA. 2011. Aortic homograft endocarditis caused by Campylobacter jejuni. J Clin Microbiol 49:4016–4017. http://dx.doi.org/10.1128/JCM.00935-11.
235. Haruyama A, Toyoda S, Kikuchi M, Arikawa T, Inami S, Otani N, Amano H, Matsuda R, Inoue T. 2011. Campylobacter fetus as cause of prosthetic valve endocarditis. Tex Heart Inst J 38:584–587.
236. Caramelli B, Mansur AJ, Grinberg M, Mendes CM, Pileggi F. 1988. Campylobacter fetus endocarditis on a prosthetic heart valve. South Med J 81:802–803. http://dx.doi.org/10.1097/00007611-198806000-00028.
237. Peetermans WE, De Man F, Moerman P, van de Werf F. 2000. Fatal prosthetic valve endocarditis due to Campylobacter fetus. J Infect 41:180–182. http://dx.doi.org/10.1053/jinf.2000.0699.
238. Morrison VA, Lloyd BK, Chia JK, Tuazon CU. 1990. Cardiovascular and bacteremic manifestations of Campylobacter fetus infection: case report and review. Rev Infect Dis 12:387–392. http://dx.doi.org/10.1093/clinids/12.3.387.
239. Prendki V, Marmor S, Zeller V, Lhotellier L, Megraud F, Desplaces N. 2013. Campylobacter infection after prosthetic joint surgery. Scand J Infect Dis 45:706–710. http://dx.doi.org/10.3109/00365548.2013.800225.
240. Kell RJA, Ellis ME. 1985. Transient atrial fibrillation in Campylobacter jejuni infection. BMJ 291:1542. http://dx.doi.org/10.1136/bmj.291.6508.1542.
241. Bucknell SJ, Le T, Amerena J, Hill DG, McDonald M. 2000. Aortic dissection associated with Campylobacter aortitis. Heart Lung Circ 9:88–91. http://dx.doi.org/10.1046/j.1444-2892.2000.00027.x.
242. Abassade P, Cremieux O, Korach JM, Templier F, Morette C, Wolff M, Baudouy PY, Farge C. 1994. Campylobacter fetus subspecies fetus endoaortitis on a Bentall tube prosthesis. Apropos of a case. Arch Mal Coeur Vaiss 87:1483–1487.
243. Blabey RG, Jr, Parry MF, Bull SM, Weed CB. 1983. Mycotic aneurysm of the abdominal aorta: successful management of Campylobacter fetus aortitis. Conn Med 47:129–130.
244. Gazaigne L, Legrand P, Renaud B, Bourra B, Taillandier E, Brun- Buisson C, Lesprit P. 2008. Campylobacter fetus bloodstream infection: risk factors and clinical features. Eur J Clin Microbiol Infect Dis 27:185–189. http://dx.doi.org/10.1007/s10096-007-0415-0.
245. Thomas K, Chan KN, Ribeiro CD. 1980. Campylobacter jejuni/coli meningitis in a neonate. Br Med J 280:1301–1302. http://dx.doi.org/10.1136/bmj.280.6227.1301.
246. Goossens H, Henocque G, Kremp L, Rocque J, Boury R, Alanio G, Vlaes L, Hemelhof W, Van den Borre C, Macart M, et al. 1986. Nosocomial outbreak of Campylobacter jejuni meningitis in newborn infants. Lancet ii:146–149.
247. Ruef C, Fah L, Caduff F. 1988. Campylobacter jejuni: sepsis and meningitis in an adult without risk factors. Schweiz Med Wochenschr 118: 302–304.
248. Dronda F, Garcia-Arata I, Navas E, de Rafael L. 1998. Meningitis in adults due to Campylobacter fetus subspecies fetus. Clin Infect Dis 27: 906–907. http://dx.doi.org/10.1086/517168.
249. Burch KL, Saeed K, Sails AD, Wright PA. 1999. Successful treatment by meropenem of Campylobacter jejuni meningitis in a chronic alcoholic following neurosurgery. J Infect 39:241–243. http://dx.doi.org/10.1016/S0163-4453(99)90059-2.
250. Umehara Y, Kudo M, Kawasaki M. 2009. Campylobacter fetus meningitis in a patient with Crohn’s disease. Inflamm Bowel Dis 15:645–646. http://dx.doi.org/10.1002/ibd.20686.
251. Kogawa S, Furukawa K. 2010. Campylobacter jejuni meningitis in an immunocompetent adult male. Rinsho Shinkeigaku 50:262–264. http://dx.doi.org/10.5692/clinicalneurol.50.262.
252. Tsoni K, Papadopoulou E, Michailidou E, Kavaliotis I. 2013. Campylobacter jejuni meningitis in a neonate: a rare case report. J Neonatal Perinatal Med 6:183–185. http://dx.doi.org/10.3233/NPM-1366612.
253. Spiegel CA, Telford G. 1984. Isolation of Wolinella recta and Actinomyces viscosus from an actinomycotic chest wall mass. J Clin Microbiol 20: 1187–1189.
254. Han XY, Tarrand JJ, Rice DC. 2005. Oral Campylobacter species involved in extraoral abscess: a report of three cases. J Clin Microbiol 43: 2513–2515. http://dx.doi.org/10.1128/JCM.43.5.2513-2515.2005.
255. de Vries JJ, Arents NL, Manson WL. 2008. Campylobacter species isolated from extra-oro-intestinal abscesses: a report of four cases and literature review. Eur J Clin Microbiol Infect Dis 27:1119–1123. http://dx.doi.org/10.1007/s10096-008-0550-2.
256. Batz MB, Henke E, Kowalcyk B. 2013. Long-term consequences of foodborne infections. Infect Dis Clin North Am 27:599–616. http://dx.doi.org/10.1016/j.idc.2013.05.003.
257. Pope JE, Krizova A, Garg AX, Thiessen-Philbrook H, Ouimet JM. 2007. Campylobacter reactive arthritis: a systematic review. Semin Arthritis Rheum 37:48–55. http://dx.doi.org/10.1016/j.semarthrit.2006.12.006.
258. Ajene AN, Fischer Walker CL, Black RE. 2013. Enteric pathogens and reactive arthritis: a systematic review of Campylobacter, Salmonella and Shigella-associated reactive arthritis. J Health Popul Nutr 31:299–307.
259. Simor AE, Karmali MA, Jadavji T, Roscoe M. 1986. Abortion and perinatal sepsis associated with Campylobacter infection. Rev Infect Dis 8:397–402. http://dx.doi.org/10.1093/clinids/8.3.397.
260. Gurgan T, Diker KS. 1994. Abortion associated with Campylobacter upsaliensis. J Clin Microbiol 32:3093–3094.
261. Mendz GL, Petersen R, Quinlivan JA, Kaakoush NO. 2014. Potential involvement of Campylobacter curvus and Haemophilus parainfluenzae in preterm birth. BMJ Case Rep 2014:bcr2014205282. http://dx.doi.org/10.1136/bcr-2014-205282.
262. Arce RM, Barros SP, Wacker B, Peters B, Moss K, Offenbacher S. 2009. Increased TLR4 expression in murine placentas after oral infection with periodontal pathogens. Placenta 30:156–162. http://dx.doi.org/10.1016/j.placenta.2008.11.017.
263. Arce RM, Caron KM, Barros SP, Offenbacher S. 2012. Toll-like receptor 4 mediates intrauterine growth restriction after systemic Campylobacter rectus infection in mice. Mol Oral Microbiol 27:373–381. http://dx.doi.org/10.1111/j.2041-1014.2012.00651.x.
264. Lastovica AJ, le Roux E. 2000. Efficient isolation of campylobacteria from stools. J Clin Microbiol 38:2798–2799.
265. Kim SA, Lee YM, Hwang IG, Kang DH, Woo GJ, Rhee MS. 2009. Eight enrichment broths for the isolation of Campylobacter jejuni from inoculated suspensions and ground pork. Lett Appl Microbiol 49:620–626. http://dx.doi.org/10.1111/j.1472-765X.2009.02714.x.
266. Iwamoto M, Huang JY, Cronquist AB, Medus C, Hurd S, Zansky S, Dunn J, Woron AM, Oosmanally N, Griffin PM, Besser J, Henao OL. 2015. Bacterial enteric infections detected by culture-independent diagnostic tests—FoodNet, United States, 2012–2014. MMWRMorb Mortal Wkly Rep 64:252–257.
267. Kulkarni SP, Lever S, Logan JM, Lawson AJ, Stanley J, Shafi MS. 2002. Detection of Campylobacter species: a comparison of culture and polymerase chain reaction based methods. J Clin Pathol 55:749–753. http://dx.doi.org/10.1136/jcp.55.10.749.
268. Maher M, Finnegan C, Collins E, Ward B, Carroll C, Cormican M. 2003. Evaluation of culture methods and a DNA probe-based PCR assay for detection of Campylobacter species in clinical specimens of feces. J Clin Microbiol 41:2980–2986. http://dx.doi.org/10.1128/JCM.41.7.2980-2986.2003.
269. On SL. 2001. Taxonomy of Campylobacter, Arcobacter, Helicobacter and related bacteria: current status, future prospects and immediate concerns. Symp Ser Soc Appl Microbiol 2001:1S–15S. http://dx.doi.org/10.1046/j.1365-2672.2001.01349.x.
270. Man SM, Kaakoush NO, Octavia S, Mitchell H. 2010. The internal transcribed spacer region, a new tool for use in species differentiation and delineation of systematic relationships within the Campylobacter genus. Appl Environ Microbiol 76:3071–3081. http://dx.doi.org/10.1128/AEM.02551-09.
271. Eyers M, Chapelle S, Van Camp G, Goossens H, De Wachter R. 1993. Discrimination among thermophilic Campylobacter species by polymerase chain reaction amplification of 23S rRNA gene fragments. J Clin Microbiol 31:3340–3343.
272. Fermer C, Engvall EO. 1999. Specific PCR identification and differentiation of the thermophilic campylobacters, Campylobacter jejuni, C. coli, C. lari, and C. upsaliensis. J Clin Microbiol 37:3370–3373.
273. Christensen H, Jorgensen K, Olsen JE. 1999. Differentiation of Campylobacter coli and C. jejuni by length and DNA sequence of the 16S-23S rRNA internal spacer region. Microbiology 145:99–105. http://dx.doi.org/10.1099/13500872-145-1-99.
274. Hurtado A, Owen RJ. 1997. A molecular scheme based on 23S rRNA gene polymorphisms for rapid identification of Campylobacter and Arcobacter species. J Clin Microbiol 35:2401–2404.
275. Granato PA, Chen L, Holiday I, Rawling RA, Novak-Weekley SM, Quinlan T, Musser KA. 2010. Comparison of premier CAMPY enzyme immunoassay (EIA), ProSpecT Campylobacter EIA, and ImmunoCard STAT! CAMPY tests with culture for laboratory diagnosis of Campylobacter enteric infections. J Clin Microbiol 48:4022–4027. http://dx.doi.org/10.1128/JCM.00486-10.
276. Javed MA, Poshtiban S, Arutyunov D, Evoy S, Szymanski CM. 2013. Bacteriophage receptor binding protein based assays for the simultaneous detection of Campylobacter jejuni and Campylobacter coli. PLoS One 8:e69770. http://dx.doi.org/10.1371/journal.pone.0069770.
277. Allos BM. 2001. Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis 32:1201–1206. http://dx.doi.org/10.1086/319760.
278. Smith JL, Fratamico PM. 2010. Fluoroquinolone resistance in Campylobacter. J Food Prot 73:1141–1152.
279. Luangtongkum T, Jeon B, Han J, Plummer P, Logue CM, Zhang Q. 2009. Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol 4:189–200. http://dx.doi.org/10.2217/17460913.4.2.189.
280. Graham JP, Boland JJ, Silbergeld E. 2007. Growth promoting antibiotics in food animal production: an economic analysis. Public Health Rep 122:79–87.
281. Tribble DR, Sanders JW, Pang LW, Mason C, Pitarangsi C, Baqar S, Armstrong A, Hshieh P, Fox A, Maley EA, Lebron C, Faix DJ, Lawler JV, Nayak G, Lewis M, Bodhidatta L, Scott DA. 2007. Traveler’s diarrhea in Thailand: randomized, double-blind trial comparing singledose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen. Clin Infect Dis 44:338–346. http://dx.doi.org/10.1086/510589.
282. Vukelic D, Trkulja V, Salkovic-Petrisic M. 2010. Single oral dose of azithromycin versus 5 days of oral erythromycin or no antibiotic in treatment of Campylobacter enterocolitis in children: a prospective randomized assessor-blind study. J Pediatr Gastroenterol Nutr 50:404–410. http://dx.doi.org/10.1097/MPG.0b013e3181a87104.
283. McEwen SA, Fedorka-Cray PJ. 2002. Antimicrobial use and resistance in animals. Clin Infect Dis 34(Suppl 3):S93–S106. http://dx.doi.org/10.1086/340246.
284. Wieczorek K, Osek J. 2013. Antimicrobial resistance mechanisms among Campylobacter. Biomed Res Int 2013:340605. http://dx.doi.org/10.1155/2013/340605.
285. Garin B, Gouali M, Wouafo M, Perchec AM, Pham MT, Ravaonindrina N, Urbes F, Gay M, Diawara A, Leclercq A, Rocourt J, Pouillot R. 2012. Prevalence, quantification and antimicrobial resistance of Campylobacter spp. on chicken neck-skins at points of slaughter in 5 major cities located on 4 continents. Int J Food Microbiol 157:102–107. http://dx.doi.org/10.1016/j.ijfoodmicro.2012.04.020.
286. Hakanen AJ, Lehtopolku M, Siitonen A, Huovinen P, Kotilainen P. 2003. Multidrug resistance in Campylobacter jejuni strains collected from Finnish patients during 1995–2000. J Antimicrob Chemother 52:1035–1039. http://dx.doi.org/10.1093/jac/dkg489.
287. Qin SS, Wu CM, Wang Y, Jeon B, Shen ZQ, Zhang Q, Shen JZ. 2011. Antimicrobial resistance in Campylobacter coli isolated from pigs in two provinces of China. Int J Food Microbiol 146:94–98. http://dx.doi.org/10.1016/j.ijfoodmicro.2011.01.035.
288. Nelson JM, Smith KE, Vugia DJ, Rabatsky-Ehr T, Segler SD, Kassenborg HD, Zansky SM, Joyce K, Marano N, Hoekstra RM, Angulo FJ. 2004. Prolonged diarrhea due to ciprofloxacin-resistant Campylobacter infection. J Infect Dis 190:1150–1157. http://dx.doi.org/10.1086/423282.
289. Helms M, Simonsen J, Olsen KE, Molbak K. 2005. Adverse health events associated with antimicrobial drug resistance in Campylobacter species: a registry-based cohort study. J Infect Dis 191:1050–1055. http://dx.doi.org/10.1086/428453.
290. Quinn T, Bolla JM, Pages JM, Fanning S. 2007. Antibiotic-resistant Campylobacter: could efflux pump inhibitors control infection? J Antimicrob Chemother 59:1230–1236. http://dx.doi.org/10.1093/jac/dkl470.
291. Qin S, Wang Y, Zhang Q, Chen X, Shen Z, Deng F, Wu C, Shen J. 2012. Identification of a novel genomic island conferring resistance to multiple aminoglycoside antibiotics in Campylobacter coli. Antimicrob Agents Chemother 56:5332–5339. http://dx.doi.org/10.1128/AAC.00809-12.
292. Moore JE, Barton MD, Blair IS, Corcoran D, Dooley JS, Fanning S, Kempf I, Lastovica AJ, Lowery CJ, Matsuda M, McDowell DA, Mc- Mahon A, Millar BC, Rao JR, Rooney PJ, Seal BS, Snelling WJ, Tolba O. 2006. The epidemiology of antibiotic resistance in Campylobacter. Microbes Infect 8:1955–1966. http://dx.doi.org/10.1016/j.micinf.2005.12.030.
293. Domingues AR, Pires SM, Halasa T, Hald T. 2012. Source attribution of human campylobacteriosis using a meta-analysis of case-control studies of sporadic infections. Epidemiol Infect 140:970–981. http://dx.doi.org/10.1017/S0950268811002676.
294. Swaminathan A, Torresi J, Schlagenhauf P, Thursky K, Wilder-Smith A, Connor BA, Schwartz E, Vonsonnenberg F, Keystone J, O’Brien DP. 2009. A global study of pathogens and host risk factors associated with infectious gastrointestinal disease in returned international travellers. J Infect 59:19–27. http://dx.doi.org/10.1016/j.jinf.2009.05.008.
295. Ravel A, Nesbitt A, Marshall B, Sittler N, Pollari F. 2011. Description and burden of travel-related cases caused by enteropathogens reported in a Canadian community. J Travel Med 18:8–19. http://dx.doi.org/10.1111/j.1708-8305.2010.00471.x.
296. Ricotta EE, Palmer A, Wymore K, Clogher P, Oosmanally N, Robinson T, Lathrop S, Karr J, Hatch J, Dunn J, Ryan P, Blythe D. 2014. Epidemiology and antimicrobial resistance of international travelassociated Campylobacter infections in the United States, 2005–2011. Am J Public Health 104:e108–e114. http://dx.doi.org/10.2105/AJPH.2013.301867.
297. Zinszer K, Michel P, Hardardottir H, Kristinsson KG, Sigmundsdottir G, St-Onge L, Reiersen J, Charland K, Lowman R. 2010. The impact of domestic travel on estimating regional rates of human campylobacteriosis. Epidemiol Infect 138:1735–1743. http://dx.doi.org/10.1017/S0950268810001081.
298. Gautret P, Cramer JP, Field V, Caumes E, Jensenius M, Gkrania- Klotsas E, de Vries PJ, Grobusch MP, Lopez-Velez R, Castelli F, Schlagenhauf P, Hervius Askling H, von Sonnenburg F, Lalloo DG, Loutan L, Rapp C, Basto F, Santos O’Connor F, Weld L, Parola P. 2012. Infectious diseases among travellers and migrants in Europe, EuroTravNet 2010. Euro Surveill 17:20205. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId_20205.
299. Zenner D, Gillespie I. 2011. Travel-associated Salmonella and Campylobacter gastroenteritis in England: estimation of under-ascertainment through national laboratory surveillance. J Travel Med 18:414–417. http://dx.doi.org/10.1111/j.1708-8305.2011.00553.x.
300. Mughini-Gras L, Smid JH, Wagenaar JA, De Boer A, Havelaar AH, Friesema IH, French NP, Graziani C, Busani L, Van Pelt W. 2014. Campylobacteriosis in returning travellers and potential secondary transmission of exotic strains. Epidemiol Infect 142:1277–1288. http://dx.doi.org/10.1017/S0950268813002069.
301. Kapperud G, Skjerve E, Bean NH, Ostroff SM, Lassen J. 1992. Risk factors for sporadic Campylobacter infections: results of a case-control study in southeastern Norway. J Clin Microbiol 30:3117–3121.
302. Neimann J, Engberg J, Molbak K, Wegener HC. 2003. A case-control study of risk factors for sporadic Campylobacter infections in Denmark. Epidemiol Infect 130:353–366.
303. Greig JD, Ravel A. 2009. Analysis of foodborne outbreak data reported internationally for source attribution. Int J Food Microbiol 130:77–87. http://dx.doi.org/10.1016/j.ijfoodmicro.2008.12.031.
304. Pires SM, Vigre H, Makela P, Hald T. 2010. Using outbreak data for source attribution of human salmonellosis and campylobacteriosis in Europe. Foodborne Pathog Dis 7:1351–1361. http://dx.doi.org/10.1089/fpd.2010.0564.
305. Strachan NJ, Gormley FJ, Rotariu O, Ogden ID, Miller G, Dunn GM, Sheppard SK, Dallas JF, Reid TM, Howie H, Maiden MC, Forbes KJ. 2009. Attribution of Campylobacter infections in northeast Scotland to specific sources by use of multilocus sequence typing. J Infect Dis 199: 1205–1208. http://dx.doi.org/10.1086/597417.
306. Sheppard SK, Colles F, Richardson J, Cody AJ, Elson R, Lawson A, Brick G, Meldrum R, Little CL, Owen RJ, Maiden MC, McCarthy ND. 2010. Host association of Campylobacter genotypes transcends geographic variation. Appl Environ Microbiol 76:5269–5277. http://dx.doi.org/10.1128/AEM.00124-10.
307. Strachan NJ, MacRae M, Thomson A, Rotariu O, Ogden ID, Forbes KJ. 2012. Source attribution, prevalence and enumeration of Campylobacter spp. from retail liver. Int J Food Microbiol 153:234–236. http://dx.doi.org/10.1016/j.ijfoodmicro.2011.10.033.
308. Mughini Gras L, Smid JH, Wagenaar JA, de Boer AG, Havelaar AH, Friesema IH, French NP, Busani L, van Pelt W. 2012. Risk factors for campylobacteriosis of chicken, ruminant, and environmental origin: a combined case-control and source attribution analysis. PLoS One 7:e42599. http://dx.doi.org/10.1371/journal.pone.0042599.
309. Ragimbeau C, Colin S, Devaux A, Decruyenaere F, Cauchie HM, Losch S, Penny C, Mossong J. 2014. Investigating the host specificity of Campylobacter jejuni and Campylobacter coli by sequencing gyrase subunit A. BMC Microbiol 14:205. http://dx.doi.org/10.1186/s12866-014-0205-7.
310. Baily JL, Meric G, Bayliss S, Foster G, Moss SE, Watson E, Pascoe B, Mikhail J, Pizzi R, Goldstone RJ, Smith DG, Willoughby K, Hall AJ, Sheppard SK, Dagleish MP. 2015. Evidence of land-sea transfer of the zoonotic pathogen Campylobacter to a wildlife marine sentinel species. Mol Ecol 24:208–221. http://dx.doi.org/10.1111/mec.13001.
311. Kownhar H, Shankar EM, Rajan R, Vengatesan A, Rao UA. 2007. Prevalence of Campylobacter jejuni and enteric bacterial pathogens among hospitalized HIV infected versus non-HIV infected patients with diarrhoea in southern India. Scand J Infect Dis 39:862–866. http://dx.doi.org/10.1080/00365540701393096.
312. Larsen IK, Gradel KO, Helms M, Hornstrup MK, Jurgens G, Mens H, Rosager CL, Clausen TH, Kronborg G, Nielsen H. 2011. Nontyphoidal Salmonella and Campylobacter infections among HIV-positive patients in Denmark. Scand J Infect Dis 43:3–7. http://dx.doi.org/10.3109/00365548.2010.517780.
313. Skirrow MB. 1977. Campylobacter enteritis: a “new” disease. Br Med J 2:9–11. http://dx.doi.org/10.1136/bmj.2.6078.9.
314. Ellis-Iversen J, Ridley A, Morris V, Sowa A, Harris J, Atterbury R, Sparks N, Allen V. 2012. Persistent environmental reservoirs on farms as risk factors for Campylobacter in commercial poultry. Epidemiol Infect 140:916–924. http://dx.doi.org/10.1017/S095026881100118X.
315. Gu W, Siletzky RM, Wright S, Islam M, Kathariou S. 2009. Antimicrobial susceptibility profiles and strain type diversity of Campylobacter jejuni isolates from turkeys in eastern North Carolina. Appl Environ Microbiol 75:474–482. http://dx.doi.org/10.1128/AEM.02012-08.
316. Giacomelli M, Andrighetto C, Lombardi A, Martini M, Piccirillo A. 2012. A longitudinal study on thermophilic Campylobacter spp. in commercial turkey flocks in northern Italy: occurrence and genetic diversity. Avian Dis 56:693–700. http://dx.doi.org/10.1637/10141-032312-Reg.1.
317. Colles FM, Ali JS, Sheppard SK, McCarthy ND, Maiden MC. 2011. Campylobacter populations in wild and domesticated mallard ducks (Anas platyrhynchos). Environ Microbiol Rep 3:574–580. http://dx.doi.org/10.1111/j.1758-2229.2011.00265.x.
318. Tresierra-Ayala A, Bendayan ME, Bernuy A, Pereyra G, Fernandez H. 1994. Chicken as potential contamination source of Campylobacter lari in Iquitos, Peru. Rev Inst Med Trop Sao Paulo 36:497–499.
319. Kaakoush NO, Sodhi N, Chenu JW, Cox JM, Riordan SM, Mitchell HM. 2014. The interplay between Campylobacter and Helicobacter species and other gastrointestinal microbiota of commercial broiler chickens. Gut Pathog 6:18. http://dx.doi.org/10.1186/1757-4749-6-18.
320. Boysen L, Rosenquist H, Larsson JT, Nielsen EM, Sorensen G, Nordentoft S, Hald T. 2014. Source attribution of human campylobacteriosis in Denmark. Epidemiol Infect 142:1599–1608. http://dx.doi.org/10.1017/S0950268813002719.
321. Kittl S, Heckel G, Korczak BM, Kuhnert P. 2013. Source attribution of human Campylobacter isolates by MLST and fla-typing and association of genotypes with quinolone resistance. PLoS One 8:e81796. http://dx.doi.org/10.1371/journal.pone.0081796.
322. Wei W, Schupbach G, Held L. 2014. Time-series analysis of Campylobacter incidence in Switzerland. Epidemiol Infect 2014:1–8. http://dx.doi.org/10.1017/S0950268814002738.
323. Byrd JA, Corrier DE, Hume ME, Bailey RH, Stanker LH, Hargis BM. 1998. Incidence of Campylobacter in crops of preharvest market-age broiler chickens. Poult Sci 77:1303–1305. http://dx.doi.org/10.1093/ps/77.9.1303.
324. Ahmed MF, Schulz J, Hartung J. 2013. Survival of Campylobacter jejuni in naturally and artificially contaminated laying hen feces. Poult Sci 92: 364–369. http://dx.doi.org/10.3382/ps.2012-02496.
325. Food Standards Agency. 2014, posting date. A microbiological survey of Campylobacter contamination in fresh whole UK-produced chilled chickens at retail sale—interim report to cover quarters 1–3. Food Standards Agency, London, United Kingdom.
326. Deckert AE, Taboada E, Mutschall S, Poljak Z, Reid-Smith RJ, Tamblyn S, Morrell L, Seliske P, Jamieson FB, Irwin R, Dewey CE, Boerlin P, McEwen SA. 2014. Molecular epidemiology of Campylobacter jejuni human and chicken isolates from two health units. Foodborne Pathog Dis 11:150–155. http://dx.doi.org/10.1089/fpd.2013.1610.
327. Levesque S, Fournier E, Carrier N, Frost E, Arbeit RD, Michaud S. 2013. Campylobacteriosis in urban versus rural areas: a case-case study integrated with molecular typing to validate risk factors and to attribute sources of infection. PLoS One 8:e83731. http://dx.doi.org/10.1371/journal.pone.0083731.
328. Rosenquist H, Boysen L, Krogh AL, Jensen AN, Nauta M. 2013. Campylobacter contamination and the relative risk of illness from organic broiler meat in comparison with conventional broiler meat. Int J Food Microbiol 162:226–230. http://dx.doi.org/10.1016/j.ijfoodmicro.2013.01.022.
329. Blaser MJ, LaForce FM, Wilson NA, Wang WL. 1980. Reservoirs for human campylobacteriosis. J Infect Dis 141:665–669. http://dx.doi.org/10.1093/infdis/141.5.665.
330. Moore JE, Wilson TS, Wareing DR, Humphrey TJ, Murphy PG. 2002. Prevalence of thermophilic Campylobacter spp. in ready-to-eat foods and raw poultry in northern Ireland. J Food Prot 65:1326–1328.
331. Levallois P, Chevalier P, Gingras S, Dery P, Payment P, Michel P, Rodriguez M. 2014. Risk of infectious gastroenteritis in young children living in Quebec rural areas with intensive animal farming: results of a case-control study (2004–2007). Zoonoses Public Health 61:28–38. http://dx.doi.org/10.1111/zph.12039.
332. de Perio MA, Niemeier RT, Levine SJ, Gruszynski K, Gibbins JD. 2013. Campylobacter infection in poultry-processing workers, Virginia, USA, 2008–2011. Emerg Infect Dis 19:286–288. http://dx.doi.org/10.3201/eid1902.121147.
333. Nielsen EM. 2002. Occurrence and strain diversity of thermophilic campylobacters in cattle of different age groups in dairy herds. Lett Appl Microbiol 35:85–89. http://dx.doi.org/10.1046/j.1472-765X.2002.01143.x.
334. Ellis-Iversen J, Cook AJ, Smith RP, Pritchard GC, Nielen M. 2009. Temporal patterns and risk factors for Escherichia coli O157 and Campylobacter spp. in young cattle. J Food Prot 72:490–496.
335. Stanley KN, Wallace JS, Currie JE, Diggle PJ, Jones K. 1998. The seasonal variation of thermophilic campylobacters in beef cattle, dairy cattle and calves. J Appl Microbiol 85:472–480. http://dx.doi.org/10.1046/j.1365-2672.1998.853511.x.
336. Leatherbarrow AJ, Griffiths R, Hart CA, Kemp R, Williams NJ, Diggle PJ, Wright EJ, Sutherst J, Houghton P, French NP. 2007. Campylobacter lari: genotype and antibiotic resistance of isolates from cattle, wildlife and water in an area of mixed dairy farmland in the United Kingdom. Environ Microbiol 9:1772–1779. http://dx.doi.org/10.1111/j.1462-2920.2007.01295.x.
337. Guevremont E, Normand V, Lamoureux L, Cote C. 2008. Genetic detection of Campylobacter lanienae in fecal matter and stored manure from swine and dairy cattle. Foodborne Pathog Dis 5:361–364. http://dx.doi.org/10.1089/fpd.2007.0054.
338. Harvey RB, Young CR, Anderson RC, Droleskey RE, Genovese KJ, Egan LF, Nisbet DJ. 2000. Diminution of Campylobacter colonization in neonatal pigs reared off-sow. J Food Prot 63:1430–1432.
339. Weijtens MJ, Bijker PG, Van der Plas J, Urlings HA, Biesheuvel MH. 1993. Prevalence of Campylobacter in pigs during fattening; an epidemiological study. Vet Q 15:138–143. http://dx.doi.org/10.1080/01652176.1993.9694392.
340. Alter T, Gaull F, Kasimir S, Gurtler M, Mielke H, Linnebur M, Fehlhaber K. 2005. Prevalences and transmission routes of Campylobacter spp. strains within multiple pig farms. Vet Microbiol 108:251–261. http://dx.doi.org/10.1016/j.vetmic.2005.03.004.
341. Raji MA, Adekeye JO, Kwaga JK, Bale JO. 2000. Bioserogroups of Campylobacter species isolated from sheep in Kaduna State, Nigeria. SmallRuminRes 37:215–221. http://dx.doi.org/10.1016/S0921-4488(00)00125-5.
342. Zweifel C, Zychowska MA, Stephan R. 2004. Prevalence and characteristics of Shiga toxin-producing Escherichia coli, Salmonella spp. and Campylobacter spp. isolated from slaughtered sheep in Switzerland. Int J Food Microbiol 92:45–53. http://dx.doi.org/10.1016/j.ijfoodmicro.2003.07.005.
343. Cortes C, de la Fuente R, Contreras A, Sanchez A, Corrales JC, Martinez S, Orden JA. 2006. A survey of Salmonella spp and Campylobacter spp in dairy goat faeces and bulk tank milk in the Murcia region of Spain. Ir Vet J 59:391–393. http://dx.doi.org/10.1186/2046-0481-59-7-391.
344. Baker J, Barton MD, Lanser J. 1999. Campylobacter species in cats and dogs in South Australia. Aust Vet J 77:662–666. http://dx.doi.org/10.1111/j.1751-0813.1999.tb13159.x.
345. Chaban B, Ngeleka M, Hill JE. 2010. Detection and quantification of 14 Campylobacter species in pet dogs reveals an increase in species richness in feces of diarrheic animals. BMC Microbiol 10:73. http://dx.doi.org/10.1186/1471-2180-10-73.
346. Fox JG, Zanotti S, Jordan HV. 1981. The hamster as a reservoir of Campylobacter fetus subspecies jejuni. J Infect Dis 143:856. http://dx.doi.org/10.1093/infdis/143.6.856.
347. Fox JG, Hering AM, Ackerman JI, Taylor NS. 1983. The pet hamster as a potential reservoir of human campylobacteriosis. J Infect Dis 147:784. http://dx.doi.org/10.1093/infdis/147.4.784.
348. Fox JG, Ackerman JI, Newcomer CE. 1983. Ferret as a potential reservoir for human campylobacteriosis. Am J Vet Res 44:1049–1052.
349. Giacomelli M, Piccirillo A. 2014. Pet reptiles as potential reservoir of Campylobacter species with zoonotic potential. Vet Rec 174:479. http://dx.doi.org/10.1136/vr.102243.
350. Kohler R, Krause G, Beutin L, Stephan R, Zweifel C. 2008. Shedding of food-borne pathogens and microbiological carcass contamination in rabbits at slaughter. Vet Microbiol 132:149–157. http://dx.doi.org/10.1016/j.vetmic.2008.04.020.
351. Luechtefeld NA, Blaser MJ, Reller LB, Wang WL. 1980. Isolation of Campylobacter fetus subsp. jejuni from migratory waterfowl. J Clin Microbiol 12:406–408.
352. Kapperud G, Rosef O. 1983. Avian wildlife reservoir of Campylobacter fetus subsp. jejuni, Yersinia spp., and Salmonella spp. in Norway. Appl Environ Microbiol 45:375–380.
353. Levre E, Valentini P, Brunetti M, Sacchelli F. 1989. Stationary and migratory avifauna as reservoirs of Salmonella, Yersinia and Campylobacter. Ann Ig 1:729–740.
354. Llarena AK, Skarp-de Haan CP, Rossi M, Hanninen ML. 2015. Characterization of the Campylobacter jejuni population in the barnacle geese reservoir. Zoonoses Public Health 62:209–221. http://dx.doi.org/10.1111/zph.12141.
355. Lillehaug A, Monceyron Jonassen C, Bergsjo B, Hofshagen M, Tharaldsen J, Nesse LL, Handeland K. 2005. Screening of feral pigeon (Colomba livia), mallard (Anas platyrhynchos) and graylag goose (Anser anser) populations for Campylobacter spp., Salmonella spp., avian influenza virus and avian paramyxovirus. Acta Vet Scand 46:193–202. http://dx.doi.org/10.1186/1751-0147-46-193.
356. Antilles N, Sanglas A, Cerda-Cuellar M. 20 September 2013. Free-living waterfowl as a source of zoonotic bacteria in a dense wild bird population area in northeastern Spain. Transbound Emerg Dis http://dx.doi.org/10.1111/tbed.12169.
357. Marin C, Palomeque MD, Marco-Jimenez F, Vega S. 2014. Wild griffon vultures (Gyps fulvus) as a source of Salmonella and Campylobacter in eastern Spain. PLoS One 9:e94191. http://dx.doi.org/10.1371/journal.pone.0094191.
358. Sippy R, Sandoval-Green CM, Sahin O, Plummer P, Fairbanks WS, Zhang Q, Blanchong JA. 2012. Occurrence and molecular analysis of Campylobacter in wildlife on livestock farms. Vet Microbiol 157:369–375. http://dx.doi.org/10.1016/j.vetmic.2011.12.026.
359. Pacha RE, Clark GW, Williams EA, Carter AM, Scheffelmaier JJ, Debusschere P. 1987. Small rodents and other mammals associated with mountain meadows as reservoirs of Giardia spp. and Campylobacter spp. Appl Environ Microbiol 53:1574–1579.
360. Wacheck S, Fredriksson-Ahomaa M, Konig M, Stolle A, Stephan R. 2010. Wild boars as an important reservoir for foodborne pathogens. Foodborne Pathog Dis 7:307–312. http://dx.doi.org/10.1089/fpd.2009.0367.
361. Bachand N, Ravel A, Onanga R, Arsenault J, Gonzalez JP. 2012. Public health significance of zoonotic bacterial pathogens from bushmeat sold in urban markets of Gabon, Central Africa. J Wildl Dis 48:785–789. http://dx.doi.org/10.7589/0090-3558-48.3.785.
362. Marin C, Ingresa-Capaccioni S, Gonzalez-Bodi S, Marco-Jimenez F, Vega S. 2013. Free-living turtles are a reservoir for Salmonella but not for Campylobacter. PLoS One 8:e72350. http://dx.doi.org/10.1371/journal.pone.0072350.
363. Petersen L, Nielsen EM, Engberg J, On SL, Dietz HH. 2001. Comparison of genotypes and serotypes of Campylobacter jejuni isolated from Danish wild mammals and birds and from broiler flocks and humans. Appl Environ Microbiol 67:3115–3121. http://dx.doi.org/10.1128/AEM.67.7.3115-3121.2001.
364. Broman T, Palmgren H, Bergstrom S, Sellin M, Waldenstrom J, Danielsson-Tham ML, Olsen B. 2002. Campylobacter jejuni in blackheaded gulls (Larus ridibundus): prevalence, genotypes, and influence on C. jejuni epidemiology. J Clin Microbiol 40:4594–4602. http://dx.doi.org/10.1128/JCM.40.12.4594-4602.2002.
365. Hiett KL, Stern NJ, Fedorka-Cray P, Cox NA, Musgrove MT, Ladely S. 2002. Molecular subtype analyses of Campylobacter spp. from Arkansas and California poultry operations. Appl Environ Microbiol 68:6220–6236. http://dx.doi.org/10.1128/AEM.68.12.6220-6236.2002.
366. Craven SE, Stern NJ, Line E, Bailey JS, Cox NA, Fedorka-Cray P. 2000. Determination of the incidence of Salmonella spp., Campylobacter jejuni, and Clostridium perfringens in wild birds near broiler chicken houses by sampling intestinal droppings. Avian Dis 44:715–720. http://dx.doi.org/10.2307/1593118.
367. Stern NJ, Myszewski MA, Barnhart HM, Dreesen DW. 1997. Flagellin A gene restriction fragment length polymorphism patterns of Campylobacter spp. isolates from broiler production sources. Avian Dis 41:899–905. http://dx.doi.org/10.2307/1592344.
368. Taylor DN, Brown M, McDermott KT. 1982. Waterborne transmission of Campylobacter enteritis. Microb Ecol 8:347–354. http://dx.doi.org/10.1007/BF02010674.
369. Rogol M, Sechter I, Falk H, Shtark Y, Alfi S, Greenberg Z, Mizrachi R. 1983. Waterborne outbreak of Campylobacter enteritis. Eur J Clin Microbiol 2:588–590. http://dx.doi.org/10.1007/BF02016571.
370. Hanninen ML, Haajanen H, Pummi T, Wermundsen K, Katila ML, Sarkkinen H, Miettinen I, Rautelin H. 2003. Detection and typing of Campylobacter jejuni and Campylobacter coli and analysis of indicator organisms in three waterborne outbreaks in Finland. Appl Environ Microbiol 69:1391–1396. http://dx.doi.org/10.1128/AEM.69.3.1391-1396.2003.
371. Richardson G, Thomas DR, Smith RM, Nehaul L, Ribeiro CD, Brown AG, Salmon RL. 2007. A community outbreak of Campylobacter jejuni infection from a chlorinated public water supply. Epidemiol Infect 135: 1151–1158. http://dx.doi.org/10.1017/S0950268807007960.
372. Kapperud G, Espeland G, Wahl E, Walde A, Herikstad H, Gustavsen S, Tveit I, Natas O, Bevanger L, Digranes A. 2003. Factors associated with increased and decreased risk of Campylobacter infection: a prospective case-control study in Norway. Am J Epidemiol 158:234–242. http://dx.doi.org/10.1093/aje/kwg139.
373. Arvanitidou M, Stathopoulos GA, Katsouyannopoulos VC. 1994. Isolation of Campylobacter and Yersinia spp. from drinking waters. J Travel Med 1:156–159. http://dx.doi.org/10.1111/j.1708-8305.1994.tb00584.x.
374. Popowski J, Lekowska-Kochaniak A, Korsak D. 1997. The incidence of heat tolerant Campylobacter in rivers and lakes of the Warsaw region. Rocz Panstw Zakl Hig 48:253–262.
375. Galanis E, Mak S, Otterstatter M, Taylor M, Zubel M, Takaro TK, Kuo M, Michel P. 2014. The association between campylobacteriosis, agriculture and drinking water: a case-case study in a region of British Columbia, Canada, 2005–2009. Epidemiol Infect 142:2075–2084. http://dx.doi.org/10.1017/S095026881400123X.
376. Hanninen ML, Niskanen M, Korhonen L. 1998. Water as a reservoir for Campylobacter jejuni infection in cows studied by serotyping and pulsedfield gel electrophoresis (PFGE). Zentralbl Veterinarmed B 45:37–42.
377. Carter PE, McTavish SM, Brooks HJ, Campbell D, Collins-Emerson JM, Midwinter AC, French NP. 2009. Novel clonal complexes with an unknown animal reservoir dominate Campylobacter jejuni isolates from river water in New Zealand. Appl Environ Microbiol 75:6038–6046. http://dx.doi.org/10.1128/AEM.01039-09.
378. Champion OL, Gaunt MW, Gundogdu O, Elmi A, Witney AA, Hinds J, Dorrell N, Wren BW. 2005. Comparative phylogenomics of the foodborne pathogen Campylobacter jejuni reveals genetic markers predictive of infection source. Proc Natl Acad SciUSA102:16043–16048. http://dx.doi.org/10.1073/pnas.0503252102.
379. Vally H, Glass K, Ford L, Hall G, Kirk MD, Shadbolt C, Veitch M, Fullerton KE, Musto J, Becker N. 2014. Proportion of illness acquired by foodborne transmission for nine enteric pathogens in Australia: an expert elicitation. Foodborne Pathog Dis 11:727–733. http://dx.doi.org/10.1089/fpd.2014.1746.
380. Centers for Disease Control and Prevention. 2013. Recurrent outbreak of Campylobacter jejuni infections associated with a raw milk dairy— Pennsylvania, April-May 2013. MMWR Morb Mortal Wkly Rep 62:702.
381. Castrodale LJ, Gerlach RF, Xavier CM, Smith BJ, Cooper MP, McLaughlin JB. 2013. Sharing milk but not messages: campylobacterio- sis associated with consumption of raw milk from a cow-share program in Alaska, 2011. J Food Prot 76:744–747. http://dx.doi.org/10.4315/0362-028X.JFP-12-329.
382. Longenberger AH, Palumbo AJ, Chu AK, Moll ME, Weltman A, Ostroff SM. 2013. Campylobacter jejuni infections associated with unpasteurized milk—multiple states, 2012. Clin Infect Dis 57:263–266. http://dx.doi.org/10.1093/cid/cit231.
383. Mungai EA, Behravesh CB, Gould LH. 2015. Increased outbreaks associated with nonpasteurized milk, United States, 2007–2012. Emerg Infect Dis 21:119–122. http://dx.doi.org/10.3201/eid2101.140447.
384. Serraino A, Florio D, Giacometti F, Piva S, Mion D, Zanoni RG. 2013. Presence of Campylobacter and Arcobacter species in in-line milk filters of farms authorized to produce and sell raw milk and of a water buffalo dairy farm in Italy. J Dairy Sci 96:2801–2807. http://dx.doi.org/10.3168/jds.2012-6249.
385. Koziel M, Lucey B, Bullman S, Corcoran GD, Sleator RD. 2012. Molecular-based detection of the gastrointestinal pathogen Campylobacter ureolyticus in unpasteurized milk samples from two cattle farms in Ireland. Gut Pathog 4:14. http://dx.doi.org/10.1186/1757-4749-4-14.
386. Revez J, Zhang J, Schott T, Kivisto R, Rossi M, Hanninen ML. 2014. Genomic variation between Campylobacter jejuni isolates associated with milk-borne-disease outbreaks. J Clin Microbiol 52:2782–2786. http://dx.doi.org/10.1128/JCM.00931-14.
387. Jonsson ME, Chriel M, Norstrom M, Hofshagen M. 2012. Effect of climate and farm environment on Campylobacter spp. colonisation in Norwegian broiler flocks. Prev Vet Med 107:95–104. http://dx.doi.org/10.1016/j.prevetmed.2012.05.002.
388. Strother KO, Steelman CD, Gbur EE. 2005. Reservoir competence of lesser mealworm (Coleoptera: Tenebrionidae) for Campylobacter jejuni (Campylobacterales: Campylobacteraceae). J Med Entomol 42:42–47. http://dx.doi.org/10.1603/0022-2585(2005)042[0042:RCOLMC]2.0.CO;2.
389. Skov MN, Spencer AG, Hald B, Petersen L, Nauerby B, Carstensen B, Madsen M. 2004. The role of litter beetles as potential reservoir for Salmonella enterica and thermophilic Campylobacter spp. between broiler flocks. Avian Dis 48:9–18. http://dx.doi.org/10.1637/5698.
390. Axelsson-Olsson D, Waldenstrom J, Broman T, Olsen B, Holmberg M. 2005. Protozoan Acanthamoeba polyphaga as a potential reservoir for Campylobacter jejuni. Appl Environ Microbiol 71:987–992. http://dx.doi.org/10.1128/AEM.71.2.987-992.2005.
391. Snelling WJ, McKenna JP, Hack CJ, Moore JE, Dooley JS. 2006. An examination of the diversity of a novel Campylobacter reservoir. Arch Microbiol 186:31–40. http://dx.doi.org/10.1007/s00203-006-0119-3.
392. Barton MD. 2014. Impact of antibiotic use in the swine industry. Curr Opin Microbiol 19:9–15. http://dx.doi.org/10.1016/j.mib.2014.05.017.
393. Smith KE, Besser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH, Johnson BP, Moore KA, Osterholm MT. 1999. Quinoloneresistant Campylobacter jejuni infections in Minnesota, 1992–1998. Invest Team N Engl J Med 340:1525–1532. http://dx.doi.org/10.1056/NEJM199905203402001.
394. Gupta A, Nelson JM, Barrett TJ, Tauxe RV, Rossiter SP, Friedman CR, Joyce KW, Smith KE, Jones TF, Hawkins MA, Shiferaw B, Beebe JL, Vugia DJ, Rabatsky-Ehr T, Benson JA, Root TP, Angulo FJ. 2004. Antimicrobial resistance among Campylobacter strains, United States, 1997–2001. Emerg Infect Dis 10:1102–1109. http://dx.doi.org/10.3201/eid1006.030635.
395. Wieczorek K, Kania I, Osek J. 2013. Prevalence and antimicrobial resistance of Campylobacter spp. isolated from poultry carcasses in Poland. J Food Prot 76:1451–1455. http://dx.doi.org/10.4315/0362-028X.JFP-13-035.
396. Di Labio E, Regula G, Steiner A, Miserez R, Thomann A, Ledergerber U. 2007. Antimicrobial resistance in bacteria from Swiss veal calves at slaughter. Zoonoses Public Health 54:344–352. http://dx.doi.org/10.1111/j.1863-2378.2007.01071.x.
397. Chatre P, Haenni M, Meunier D, Botrel MA, Calavas D, Madec JY. 2010. Prevalence and antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from cattle between 2002 and 2006 in France. J Food Prot 73:825–831.
398. Cheng AC, Turnidge J, Collignon P, Looke D, Barton M, Gottlieb T. 2012. Control of fluoroquinolone resistance through successful regulation, Australia. Emerg Infect Dis 18:1453–1460. http://dx.doi.org/10.3201/eid1809.111515.
399. Egger R, Korczak BM, Niederer L, Overesch G, Kuhnert P. 2012. Genotypes and antibiotic resistance of Campylobacter coli in fattening pigs. Vet Microbiol 155:272–278. http://dx.doi.org/10.1016/j.vetmic.2011.08.012.
400. Juntunen P, Olkkola S, Hanninen ML. 2011. Longitudinal on-farm study of the development of antimicrobial resistance in Campylobacter coli from pigs before and after danofloxacin and tylosin treatments. Vet Microbiol 150:322–330. http://dx.doi.org/10.1016/j.vetmic.2011.02.008.
401. EFSA. 2011. Scientific opinion on Campylobacter in broiler meat production: control options and performance objectives and/or targets at different stages of the food chain. EFSA J 9:2105. http://dx.doi.org/10.2903/j.efsa.2011.2105.
402. Newell DG, Elvers KT, Dopfer D, Hansson I, Jones P, James S, Gittins J, Stern NJ, Davies R, Connerton I, Pearson D, Salvat G, Allen VM. 2011. Biosecurity-based interventions and strategies to reduce Campylobacter spp. on poultry farms. Appl Environ Microbiol 77:8605–8614. http://dx.doi.org/10.1128/AEM.01090-10.
403. van Gerwe T, Bouma A, Wagenaar JA, Jacobs-Reitsma WF, Stegeman A. 2010. Comparison of Campylobacter levels in crops and ceca of broilers at slaughter. Avian Dis 54:1072–1074. http://dx.doi.org/10.1637/9113-101809-ResNote.1.
404. Humphrey S, Chaloner G, Kemmett K, Davidson N, Williams N, Kipar A, Humphrey T, Wigley P. 2014. Campylobacter jejuni is not merely a commensal in commercial broiler chickens and affects bird welfare. mBio 5:e01364-14. http://dx.doi.org/10.1128/mBio.01364-14.
405. Bahrndorff S, Rangstrup-Christensen L, Nordentoft S, Hald B. 2013. Foodborne disease prevention and broiler chickens with reduced Campylobacter infection. Emerg Infect Dis 19:425–430. http://dx.doi.org/10.3201/eid1903.111593.
406. Yano S, Kira T, Morishita Y, Ishihara K, Asai T, Iwata T, Akiba M, Murase T. 2013. Colonization of chicken flocks by Campylobacter jejuni in multiple farms in Japan. Poult Sci 92:375–381. http://dx.doi.org/10.3382/ps.2012-02710.
407. Lammerding AM, Fazil A. 2000. Hazard identification and exposure assessment for microbial food safety risk assessment. Int J Food Microbiol 58:147–157. http://dx.doi.org/10.1016/S0168-1605(00)00269-5.
408. Svetoch EA, Stern NJ. 2010. Bacteriocins to control Campylobacter spp. in poultry—a review. Poult Sci 89:1763–1768. http://dx.doi.org/10.3382/ps.2010-00659.
409. Hoang KV, Stern NJ, Lin J. 2011. Development and stability of bacteriocin resistance in Campylobacter spp. J Appl Microbiol 111:1544–1550. http://dx.doi.org/10.1111/j.1365-2672.2011.05163.x.
410. Wagenaar JA, Van Bergen MA, Mueller MA, Wassenaar TM, Carlton RM. 2005. Phage therapy reduces Campylobacter jejuni colonization in broilers. Vet Microbiol 109:275–283. http://dx.doi.org/10.1016/j.vetmic.2005.06.002.
411. Atterbury RJ, Dillon E, Swift C, Connerton PL, Frost JA, Dodd CE, Rees CE, Connerton IF. 2005. Correlation of Campylobacter bacteriophage with reduced presence of hosts in broiler chicken ceca. Appl Environ Microbiol 71:4885–4887. http://dx.doi.org/10.1128/AEM.71.8.4885-4887.2005.
412. Loc Carrillo C, Atterbury RJ, el-Shibiny A, Connerton PL, Dillon E, Scott A, Connerton IF. 2005. Bacteriophage therapy to reduce Campylobacter jejuni colonization of broiler chickens. Appl Environ Microbiol 71:6554–6563. http://dx.doi.org/10.1128/AEM.71.11.6554-6563.2005.
413. El-Shibiny A, Scott A, Timms A, Metawea Y, Connerton P, Connerton I. 2009. Application of a group II Campylobacter bacteriophage to reduce strains of Campylobacter jejuni and Campylobacter coli colonizing broiler chickens. J Food Prot 72:733–740.
414. Carvalho CM, Gannon BW, Halfhide DE, Santos SB, Hayes CM, Roe JM, Azeredo J. 2010. The in vivo efficacy of two administration routes of a phage cocktail to reduce numbers of Campylobacter coli and Campylobacter jejuni in chickens. BMC Microbiol 10:232. http://dx.doi.org/10.1186/1471-2180-10-232.
415. Kittler S, Fischer S, Abdulmawjood A, Glunder G, Klein G. 2013. Effect of bacteriophage application on Campylobacter jejuni loads in commercial broiler flocks. Appl Environ Microbiol 79:7525–7533. http://dx.doi.org/10.1128/AEM.02703-13.
416. Hermans D, Van Deun K, Messens W, Martel A, Van Immerseel F, Haesebrouck F, Rasschaert G, Heyndrickx M, Pasmans F. 2011. Campylobacter control in poultry by current intervention measures ineffective: urgent need for intensified fundamental research. Vet Microbiol 152:219–228. http://dx.doi.org/10.1016/j.vetmic.2011.03.010.
417. Fischer S, Kittler S, Klein G, Glunder G. 2013. Impact of a single phage and a phage cocktail application in broilers on reduction of Campylobacter jejuni and development of resistance. PLoS One 8:e78543. http://dx.doi.org/10.1371/journal.pone.0078543.
418. Ghareeb K, Awad WA, Mohnl M, Porta R, Biarnes M, Bohm J, Schatzmayr G. 2012. Evaluating the efficacy of an avian-specific probiotic to reduce the colonization of Campylobacter jejuni in broiler chickens. Poult Sci 91:1825–1832. http://dx.doi.org/10.3382/ps.2012-02168.
419. Nishiyama K, Seto Y, Yoshioka K, Kakuda T, Takai S, Yamamoto Y, Mukai T. 2014. Lactobacillus gasseri SBT2055 reduces infection by and colonization of Campylobacter jejuni. PLoS One 9:e108827. http://dx.doi.org/10.1371/journal.pone.0108827.
420. Santini C, Baffoni L, Gaggia F, Granata M, Gasbarri R, Di Gioia D, Biavati B. 2010. Characterization of probiotic strains: an application as feed additives in poultry against Campylobacter jejuni. Int J Food Microbiol 141(Suppl 1):S98–S108. http://dx.doi.org/10.1016/j.ijfoodmicro.2010.03.039.
421. Saxena M, John B, Mu M, Van TTH, Taki A, Coloe PJ, Smooker PM. 2013. Strategies to reduce Campylobacter colonisation in chickens. Procedia Vaccinol 7:40–43. http://dx.doi.org/10.1016/j.provac.2013.06.008.
422. Annamalai T, Pina-Mimbela R, Kumar A, Binjawadagi B, Liu Z, Renukaradhya GJ, Rajashekara G. 2013. Evaluation of nanoparticleencapsulated outer membrane proteins for the control of Campylobacter jejuni colonization in chickens. Poult Sci 92:2201–2211. http://dx.doi.org/10.3382/ps.2012-03004.
423. Lake RJ, Horn BJ, Dunn AH, Parris R, Green FT, McNickle DC. 2013. Cost-effectiveness of interventions to control Campylobacter in the New Zealand poultry meat food supply. J Food Prot 76:1161–1167. http://dx.doi.org/10.4315/0362-028X.JFP-12-481.
424. Steens A, Eriksen HM, Blystad H. 2014. What are the most important infectious diseases among those _65 years: a comprehensive analysis on notifiable diseases, Norway, 1993–2011. BMC Infect Dis 14:57. http://dx.doi.org/10.1186/1471-2334-14-57.
425. Sadkowska-Todys M, Kucharczyk B. 2013. Campylobacteriosis in Poland in 2011. Przegl Epidemiol 67:227–229, 341–342.
426. O’Reilly CE, Jaron P, Ochieng B, Nyaguara A, Tate JE, Parsons MB, Bopp CA, Williams KA, Vinje J, Blanton E, Wannemuehler KA, Vulule J, Laserson KF, Breiman RF, Feikin DR, Widdowson MA, Mintz E. 2012. Risk factors for death among children less than 5 years old hospitalized with diarrhea in rural western Kenya, 2005–2007: a cohort study. PLoS Med 9:e1001256. http://dx.doi.org/10.1371/journal.pmed.1001256.
427. Lee G, Pan W, Penataro Yori P, Paredes Olortegui M, Tilley D, Gregory M, Oberhelman R, Burga R, Chavez CB, Kosek M. 2013. Symptomatic and asymptomatic Campylobacter infections associated with reduced growth in Peruvian children. PLoS Negl Trop Dis 7:e2036. http://dx.doi.org/10.1371/journal.pntd.0002036.
428. Zaidi MB, Campos FD, Estrada-Garcia T, Gutierrez F, Leon M, Chim R, Calva JJ. 2012. Burden and transmission of zoonotic foodborne disease in a rural community in Mexico. Clin Infect Dis 55:51–60. http://dx.doi.org/10.1093/cid/cis300.
429. Yu JH, Kim NY, Cho NG, Kim JH, Kang YA, Lee HG. 2010. Epidemiology of Campylobacter jejuni outbreak in a middle school in Incheon, Korea. J Korean Med Sci 25:1595–1600. http://dx.doi.org/10.3346/jkms.2010.25.11.1595.
430. Parry A, Fearnley E, Denehy E. 2012. ‘Surprise’: outbreak of Campylobacter infection associated with chicken liver pate at a surprise birthday party, Adelaide, Australia, 2012. Western Pac Surveill Response J 3:16–19. http://dx.doi.org/10.5365/wpsar.2012.3.4.011.
431. Merritt T, Combs B, Pingault N. 2011. Campylobacter outbreaks associated with poultry liver dishes. Commun Dis Intell Q Rep 35:299–300.
432. Wensley A, Coole L. 2013. Cohort study of a dual-pathogen point source outbreak associated with the consumption of chicken liver pate, UK, October 2009. J Public Health (Oxf) 35:585–589. http://dx.doi.org/10.1093/pubmed/fdt020.
433. Inns T, Foster K, Gorton R. 2010. Cohort study of a campylobacteriosis outbreak associated with chicken liver parfait, United Kingdom, June 2010. Euro Surveill 15:19704. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId_19704.
434. Griffiths SL, Salmon RL, Mason BW, Elliott C, Thomas DR, Davies C. 2010. Using the Internet for rapid investigation of an outbreak of diarrhoeal illness in mountain bikers. Epidemiol Infect 138:1704–1711. http://dx.doi.org/10.1017/S0950268810001561.
435. Farmer S, Keenan A, Vivancos R. 2012. Food-borne Campylobacter outbreak in Liverpool associated with cross-contamination from chicken liver parfait: implications for investigation of similar outbreaks. Public Health 126:657–659. http://dx.doi.org/10.1016/j.puhe.2012.02.004.
436. Abid M, Wimalarathna H, Mills J, Saldana L, Pang W, Richardson JF, Maiden MCJ, McCarthy ND. 2013. Duck liver-associated outbreak of campylobacteriosis among humans, United Kingdom, 2011. Emerg Infect Dis 9:1310–1313. http://dx.doi.org/10.3201/eid1908.121535.
437. Rasanen S, Lappalainen S, Kaikkonen S, Hamalainen M, Salminen M, Vesikari T. 2010. Mixed viral infections causing acute gastroenteritis in children in a waterborne outbreak. Epidemiol Infect 138:1227–1234. http://dx.doi.org/10.1017/S0950268809991671.
438. Breitenmoser A, Fretz R, Schmid J, Besl A, Etter R. 2011. Outbreak of acute gastroenteritis due to a washwater-contaminated water supply, Switzerland, 2008. J Water Health 9:569–576. http://dx.doi.org/10.2166/wh.2011.158.
439. Gubbels SM, Kuhn KG, Larsson JT, Adelhardt M, Engberg J, Ingildsen P, Hollesen LW, Muchitsch S, Molbak K, Ethelberg S. 2012. A waterborne outbreak with a single clone of Campylobacter jejuni in the Danish town of Koge in May 2010. Scand J Infect Dis 44:586–594. http://dx.doi.org/10.3109/00365548.2012.655773.
440. Moller-Stray J, Eriksen HM, Bruheim T, Kapperud G, Lindstedt BA, Skeie A, Sunde M, Urdahl AM, Oygard B, Vold L. 2012. Two outbreaks of diarrhoea in nurseries in Norway after farm visits, April to May 2009. Euro Surveill 17:20321. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId_20321.
441. Karagiannis I, Sideroglou T, Gkolfinopoulou K, Tsouri A, Lampousaki D, Velonakis EN, Scoulica EV, Mellou K, Panagiotopoulos T, Bonovas S. 2010. A waterborne Campylobacter jejuni outbreak on a Greek island. Epidemiol Infect 138:1726–1734. http://dx.doi.org/10.1017/S0950268810002116.
442. Gardner TJ, Fitzgerald C, Xavier C, Klein R, Pruckler J, Stroika S, McLaughlin JB. 2011. Outbreak of campylobacteriosis associated with consumption of raw peas. Clin Infect Dis 53:26–32. http://dx.doi.org/10.1093/cid/cir249.
443. Stuart TL, Sandhu J, Stirling R, Corder J, Ellis A, Misa P, Goh S, Wong B, Martiquet P, Hoang L, Galanis E. 2010. Campylobacteriosis outbreak associated with ingestion of mud during a mountain bike race. Epidemiol Infect 138:1695–1703. http://dx.doi.org/10.1017/S095026881000049X.
444. Gaudreau C, Helferty M, Sylvestre JL, Allard R, Pilon PA, Poisson M, Bekal S. 2013. Campylobacter coli outbreak in men who have sex with men, Quebec, Canada, 2010–2011. Emerg Infect Dis 19:764–767. http://dx.doi.org/10.3201/eid1905.121344.
445. Zeigler M, Claar C, Rice D, Davis J, Frazier T, Turner A, Kelley C, Capps J, Kent A, Hubbard V, Ritenour C, Tuscano C, Qiu-Shultz Z, Leaumont CF. 2014. Outbreak of campylobacteriosis associated with a long-distance obstacle adventure race—Nevada, October 2012. MMWR Morb Mortal Wkly Rep 63:375–378.
446. Bartholomew N, Brunton C, Mitchell P, Williamson J, Gilpin B. 2014. A waterborne outbreak of campylobacteriosis in the South Island of New Zealand due to a failure to implement a multi-barrier approach. J Water Health 12:555–563. http://dx.doi.org/10.2166/wh.2014.155.
447. Edwards DS, Milne LM, Morrow K, Sheridan P, Verlander NQ, Mulla R, Richardson JF, Pender A, Lilley M, Reacher M. 2014. Campylobacteriosis outbreak associated with consumption of undercooked chicken liver pate in the East of England, September 2011: identification of a dose-response risk. Epidemiol Infect 142:352–357. http://dx.doi.org/10.1017/S0950268813001222.